EurekaMag PDF full texts Chapter 35,493

Van Houtte, M.; Lecocq, P.; Mckenna, P.; Bacheler, L. 2003: Phenotypic resistance and prevalence of specific nucleoside analog mutation combinations in reverse transcriptase in a dataset of recent HIV-1 clinical isolates. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 43: 322

Kohlhepp, S.J.; Grunkemeier, G.; Leggett, J.E.; Dworkin, R.J.; Slaughter, S.E.; Gilbert, D.N. 2000: Phenotypic resistance of penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae after single and multiple in vitro exposures to ciprofloxacin , gatifloxacin , levofloxacin , moxifloxacin and trovafloxacin. Clinical Infectious Diseases 31(1): 230

Fincher, E.F.; Russell, A.J.; Marinkovich, M.P.ter 2000: Phenotypic reversion of alpha3-deficient human keratinocytes and functional studies of laminin 5. Molecular Biology of the Cell 11(Suppl): 391a-392a

Lipkin, G.; Rosenberg, M.; Brooks, P. 2003: Phenotypic reversion of melanoma in vitro suppresses metastasis in vivo. Journal of Investigative Dermatology 121(1): 1191

Keane, F.M.; Mcgrath, J.A.; Eady, R.A.J.; Pommeret, O.; Ortonne, J.P.; Meneguzzi, G.; Vailly, J. 2000: Phenotypic reversion of non-Herlitz junctional epidermolysis bullosa keratinocytes. British Journal of Dermatology 142(3): 604

Kurian, K.M.; Van Der Kammen, R.A.; Collard, J.G.; Wyllie, A.H.; Watson, C.J. 1999: Phenotypic reversion of transformed mammary epithelial cells with Tiam1. Journal of Pathology 187(Suppl): 4A

Stauber, R.E.; Hegenbarth, K.S.; Tiran, A.; Hoefler, G.; Zatloukal, K.; Stenzel, H.C. 2000: Phenotypic screening for hemochromatosis in 4000 Austrian military recruits. Hepatology 32(4 Pt 2): 489A

Wise, J.G.; Fromknecht, K. 1999: Phenotypic selection for new binding specificities from mutational/combinatorial libraries of a DNA binding protein. FASEB Journal 13(7): A1372

Vanier, C.H.; Thompson, D.B. 2001: Phenotypic selection in a disturbance-related novel environment. Ecological Society of America Annual Meeting Abstracts 86: 225

Miles, D.B. 2001: Phenotypic selection on body size and sprint performance in the tree lizard Urosaurus ornatus. Ecological Society of America Annual Meeting Abstracts 86: 158-159

Yasukawa, K.; Sawamura, D.; Mcmillan, J.; Shimizu, H. 2001: Phenotypic severity of epidermolysis bullosa simplex caused by a dominant missense mutation in the keratin 5 is exacerbated when combined with a silent missense mutation in another allele. Journal of Investigative Dermatology 117(2): 516

Schuffenhauer, S.; Albert, A.; Chahrokh Zadeh, S.; Kress, W.; Seidel, H.; Rost, I.; Buiting, K.; Meitinger, T. 2000: Phenotypic spectrum in five patients with an Angelman syndrome typical methylation pattern due to an imprinting defect. European Journal of Human Genetics 8(Suppl 1): 78

Dhiman, K.C.; Chahota, R.K. 2003: Phenotypic stability in tartary buckwheat Gaertn under dry temperate condition of Himachal Pradesh. Indian Journal of Genetics and Plant Breeding 63(2): 161-162

Soll, D.R. 2002: Phenotypic switching. Calderone, Richard A Author Candida and candidiasis Candida and candidiasis 123-142

Fries, B.C.; Serfass, E.; Casadevall, A. 2000: Phenotypic switching in Cryptococcus neoformans strain RC-2, a 24067 variant occurs in vivo and is associated with secretion of a high molecular weight glucuronoxylomannan. Abstracts of the General Meeting of the American Society for Microbiology 100: 324

Thakur, Y.P.; Singh, P.K.; Singh, B.P. 2000: Phenotypic time trend for milk yield and production efficiency traits in Jersey crossbreds. Indian Veterinary Medical Journal 24(2): 147-148

Bataller, R.; Gines, P.; Gasull, X.; Gorbig, N.; Garcia Ramallo, E.; Nicolas, J.M.; Gual, A.; Arroyo, V.; Rodes, J. 1999: Phenotypic transformation of hepatic stellate cells into myofibroblasts results in the expression of voltage-operated calcium channels. Journal of Hepatology 30(Suppl 1): 82

Yoo, K.H.; Choe, J.H.; Kim, K.B.; Hong, Y.S.; Lee, J.W.; Kim, S.K. 1999: Phenotypic transformation of tubular epithelial cells and fibroblasts following unilateral ureteral obstruction or angiotensin II infusion in the rat. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 566A

Dunkle, L.D.; Lipps, P.E. 2001: Phenotypic variability in Cercospora zeae-maydis. Phytopathology 91(6 Suppl): S24

Andermann, E.; Badhwar, A.; Seni, M.H.; Pandolfo, M.; Andermann, F. 2003: Phenotypic variability in Friedreich ataxia Spastic paraplegia in the absence of point mutations in the FRDA gene. American Journal of Human Genetics 73(5): 555

Guay-Woodford, L.M. 1999: Phenotypic variability in PKD1: the family as a starting point. Kidney International 56(1): 344-346

Somaschini, M.; Cavazza, A.; Montrasio, C.; Nogee, L.; Carrera, P. 2004: Phenotypic variability in a kindred with chronic pulmonary diseases associated with the I73T SP-C gene mutation. Biology of the Neonate 85(4): 339-340

Dickinson, J.L.; Craig, J.E.; Sale, M.; Nicholls, S.; Love, J.; Hanson, I.; Matthews, S.J.; Mackey, D.A. 1999: Phenotypic variability in a large aniridia pedigree with a novel PAX6 1410delC mutation. American Journal of Human Genetics 65(4): A292

Forlino, A.; Marini, J.C. 1999: Phenotypic variability in a murine model for the dominant negative disorder Osteogenesis Imperfecta. American Journal of Human Genetics 65(4): A46

Jansen, A.C.M.; van Wissen, S.; Defesche, J.C.; Kastelein, J.J.P. 2002: Phenotypic variability in familial hypercholesterolaemia: an update. Current Opinion in Lipidology 13(2): 165-171

Frenking, G.S.; Niehueser, J.; Stieb, N.; Kampmann, C.; Haney, D.; Mueller Forell, W.; Vetter, T.; Beck, M. 2003: Phenotypic variability in mucopolysaccharidosis type II Results of a clinical study in 20 patients. Acta Paediatrica 92(Suppl 443): 124

Parini, R.; Menni, F.; Fesslova, V.; Gioventu, M.; Ravaglia, R.; Brambillasca, F.; Bertagnoglio, B.; Hasholt, L. 2001: Phenotypic variability in the same family with Fabry disease. Journal of Inherited Metabolic Disease 24(Suppl 2): 151

Kanaan Atallah, Z.; Johnson, D.A. 2001: Phenotypic variability of Sclerotinia sclerotiorum isolates in potato fields in the Columbia Basin of Washington. Phytopathology 91(6 Suppl): S46

A.A.eel, A.I.; Rashed, M.S.; Ijist, L.; Ruiter, J.P.N.; Wanders, R.J.A. 2002: Phenotypic variability of carnitine palmityl transferase I deficiency with novel molecular defect in Saudi Arabia. American Journal of Human Genetics 71(4 Suppl): 412

Stiller, F. 1999: Phenotypic variability, deformations and post-traumatic reactions of the stem of Encrinus cf liliiformis LAMARCK from the Middle Triassic of Qingyan, south-western China. Paläontologische Zeitschrift 73(3-4): 303-318

Alpermann,T.J.; Tillmann,U.; Beszteri,B.; Cembella,A.D.; John,U. 2010: Phenotypic variation and genotypic diversity in a planktonic population of the toxigenic marine dinoflagellate Alexandrium tamarense. Journal Of Phycology: 1, 18-32

Engle, E.C.; Lee, B.A.; Sener, C.; Turgut, B.; Akarsu, A.N.; Khamis, A.R.; Mousawi, A.; Traboulsi, E.I. 1999: Phenotypic variation at the chromosome 12 CFEOM1 locus. American Journal of Human Genetics 65(4): A248

Kohlmann, W.K.; Ward, P.A.; Lynch, P.M.; Su, L.K. 2001: Phenotypic variation between two probands with FAP due to large deletions in exon 15 of the APC gene. American Journal of Human Genetics 69(4 Suppl): 253

Paskaleva, I.; Horvath, A.; Kirov, S.; Georgiev, B.; Ganev, V. 1999: Phenotypic variation in APOB3500 heterozygotes from a Bulgarian kindred with familial defective apolipoprotein B-100. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S144

Neiswanger, K.; Petiprin, S.S.; Bardi, K.M.; Ford, M.D.; Sauder, A.S.; Giles, R.F.; Weinberg, S.M.; Carter, E.S.; Cooper, M.E.; Marazita, M.L. 2001: Phenotypic variation in individuals with or without cleft palate and their unaffected family members. American Journal of Human Genetics 69(4 Suppl): 305

Cape, C.; Zaidman, G.; Bhatia, S.; Kaufman, A.; Beck, A.; Lambert, S. 2001: Phenotypic variation in ophthalmic manifestations of MIDAS syndrome associated with an Xp223 deletion. IOVS Investigative Ophthalmology and Visual Science 42(4): S114

Marcus, P.I.; Sekellick, M.J.; Ball, L.A.; Wertz, G.W. 1999: Phenotypic variation in the interferon-inducing capacity of vesicular stomatitis virus with rearranged genomes. Journal of Interferon and Cytokine Research 19(Suppl 1): S101

Ichihara, S.; Yamada, Y.; Ishihara, H.; Yokota, M. 1999: Phenotypic variation of familial hypertrophic cardiomyopathy caused by Phe110fwdarwIIe mutation in the cardiac troponin T. Circulation 100(18): I816-I817

Hughes, T.J.; Chen, W.; Grau, C.R.; Kurtzweil, N.C. 2000: Phenotypic variation within and among genotypically different isolates of Phialophora gregata. Phytopathology 90(6 Suppl): S37

Hauw, J.J.; Sazdovitch, V.; Laplanche, J.L.; Kopp, N.; Privat, N.; Delasnerie Laupretre, N.; Brandel, J.P.; Deslys, J.P.; Dormont, D.; Alperovitch, A. 1999: Phenotypic variations and prion protein genotype in sporadic Creutzfeldt-Jakob disease A neuropathological study. Neurology 52(6 Suppl 2): A418

King, A.; Rossor, M.; Doey, L.; Collinge, J.; Lantos, P. 2000: Phenotypic variations in a familial prion disease characterised by a 144 base pair insertion in the prion protein gene. Brain Pathology 10(4): 669

Vos, J.A.; Coad, J.E.; Brissette, M.D.; Myers, J.B. 2001: Phenotypic variations in the mucosal lymphoid tissue of celiac disease. FASEB Journal 15(4): A594

Sommardahl, C.S.; Cottrell, M.B.; Woychik, R.P.; Wilkinson, J.E.by 1999: Phenotypic variations of the orpk mouse model of polycystic kidney disease on the C3H genetic background. FASEB Journal 13(4 Part 1): A521

Porter, F.D.; Zhu, P.; Kratz, L.; Krakowiak, P.A.; Battaile, K.; Steiner, R.D.; Stewart, R.R.; Kelley, R.I.; Nwokoro, N.A.; Wassif, C.A. 2000: Phenotypic, biochemical, and neurophysiological characterization of a SLOS mouse model. American Journal of Human Genetics 67(4 Suppl 2): 280

Porter, F.D.; Zhu, P.; Stewart, R.R.; Wassif, C.A. 2001: Phenotypic, biochemical, and neurophysiological characterization of a Smith-Lemli-Opitz syndrome mouse model. Pediatric Research 49(4 Part 2): 181A

Janisiewicz, W.J.; Tworkoski, T.J.; Kurtzman, C.P. 2001: Phenotypic, genetic and functional characterizing of Metchnikowia pulcherrima strains that control blue mold of apple. Phytopathology 91(6 Suppl): S43

Fernandez,E.; Alegria,A.; Delgado,S.; Mayo,B. 2010: Phenotypic, genetic and technological characterization of Lactococcus garvieae strains isolated from a raw milk cheese. International Dairy Journal: 3, 142-148

Almeida, R.D.; Peluzio, J.M.; Afferri, F.S. 2010: Phenotypic, genotypic and environmental correlations in soybean cultivated under an irrigated meadow in south of Tocantins state. Bioscience Journal 26(1): 95-99

Cosentino, S.; Pisano, M.B.; Piras, C.; Corda, A. 2003: Phenotypic, genotypic and technological characteristics of lactococci isolated from traditional Fiore Sardo cheese. FEMS Congress of European Microbiologists Abstract Book 1: 107-108

Ilardi, P.; Abad, J.; Rintamäki, P.; Bernardet, J-F.; Avendaño-Herrera, R. 2010: Phenotypic, serological and molecular evidence of Chryseobacterium piscicola in farmed Atlantic salmon, Salmo salar L., in Finland. Journal of Fish Diseases 33(2): 179-181

Ferenci, P.; Berr, F.; Caca, K.; Firneisz, G.; Szalai, F.; Datz, C.; Stauber, R.; Vogel, W.; Polli, C.; Maier Dobersberger, T. 2000: Phenotypic-genotypic correlations of common mutations in European patients with Wilson disease. Hepatology 32(4 Pt 2): 415A

Keren, A.; Meiner, V.; Potekhin, M.; Galimidi, J.; Katz, A.; Weinstein, J.M.; Reisner, S.A.; Sharif, D.; Lorber, A.; Shaheen, J.; Roguin, A.; Klein, T.; Blondheim, D.; Vered, Z.; Leibowitz, D.; Shemesh, J.; Rein, A.J.J.T.; Peleg, E.; Dreyfus, M.J.; Leitersdo 2000: Phenotypic-genotypic findings in hypertrophic cardiomyopathy in the ISAAC national database. Journal of the American College of Cardiology 35(2 Suppl A): 202A

Makhdoom, Z.A.; Bross, R.J.; Kumar, A.; Ghosh, M.S.; Komar, M.J.; Varano, V.J.; Alomari, M.; Hamati, H. 2000: Phenotypic/genotypic correlations in hereditary hemochromatosis Can phenotypic expression of HFE mutation always be correlated?. Hepatology 32(4 Pt 2): 490A

Rodriguez, M.; Gelvez, N.; Lattig, M.C.; Tamayo, M. 2002: Phenotypical analysis of an affected population with Waardenburg Syndrome in Colombia. American Journal of Human Genetics 71(4 Suppl): 282

Lopez Fuertes, L.; Campos, E.; Domenech, N.; Ezquerra, A.; Castro, J.M.; Dominguez, J.; Alonso, F. 2000: Phenotypical and functional analysis of macrophages infected with PRRS virus. Veterinary Research 31(1): 42-43

Colpaert, S.A.; Vanstraelen, K.; Liu, Z.; Ade, M.; Geboes, K.; Ceuppens, J.; Rutgeerts, P. 2000: Phenotypical and functional characterization of the Antigen Presenting Cell in Crohns disease. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1337

Nguyen, X.D.; Bugert, P.; Kropshofer, H.; Eichler, H.; Beck, C.; Klueter, H. 2003: Phenotypical and immungenetical analysis of CD14- and CD34-derived dendritic cells. Genes and Immunity 4(Suppl 1): S14

Bellmann, O.; Wegner, J.; Schneider, F.; Teuscher, F.; Ender, K. 2003: Phenotypical characterisation regarding growth, hormones, and meat quality in bulls of two types of cattle as a source for segregating family structures. Journal of Dairy Science 86(Suppl 1): 97

Ishida, Y.; Nakamura, M.; Ebihara, K.; Hoshino, K.; Hashiguchi, H.; Mitsuyama, Y.; Nishimori, T.; Nakahara, D. 2000: Phenotypical characterization of Fos-positive cells in brainstem monoaminergic nuclei following intracranial self-stimulation of the medial forebrain bundle in rat. Neuroscience Research Suppl (24): S48

Seitzer, U.; Ploetz, S.G.; Behrendt, H.; Simon, H.U.; Ring, J. 2000: Phenotypical characterization of infiltrating cells in skin lesions of patients suffering from hypereosinophilic syndrome Correlation with disease manifestation. Immunobiology 203(1-2): 556-557

Franssen, M.; Van, D.K.rkhof, P.; Van Erp, P. 2003: Phenotypical characterization of transit amplifying cells in normal human epidermis. Journal of Investigative Dermatology 121(1): 0472

Goerres, M.S.; Mulder, C.J.J.; Kerckhaert, J.A.M.; Van Dijk, H. 2002: Phenotypical differences in T-lymphocytes of non-coeliacs, coeliacs and refractory coeliacs; Association to enteropathy associated T cell lymphoma. Gastroenterology 122(4 Suppl 1): A-385

Tranchant, C.; Moreira, M.C.; Fleury, M.; Koenig, M.; Warter, J.M. 2002: Phenotypical heterogeneity in ataxia-ocular apraxia 1. Neurology 58(7 Suppl 3): A38-A39

Krone, N.; Schwarz, H.P. 2000: Phenotypical heterogeneity in congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency Two families, one genotype, two phenotypes. Hormone Research 53(Suppl 2): 70

Gorduza, E.V.; Angheloni, T.; Stoica, O.; Volosduc, M.; Covic, M. 1999: Phenotypical polymorphism in X trisomy. Cytogenetics and Cell Genetics 85(1-2): 149

Abecassis, S.; Giustiniani, J.; Guigne, E.; Bensussan, A.; Bagot, M. 2004: Phenotypical study of lymphocytes infiltrating the skin in atopic dermatitis after expansion ex vivo. Journal of Investigative Dermatology 123(2)

Dabir, T.; Mckee, S. 2003: Phenotypical variability in frontonasal dysplasia. Journal of Medical Genetics 40(Suppl 1): S39

Odent, S.; Blayau, M.; Lazaro, L.; De La Pintiere, A.; Aguilela, C.; Pasquier, L.; Dubourg, C.; David, V. 2001: Phenotypical variability in loci of holoprosencephaly. American Journal of Human Genetics 69(4 Suppl): 598

Metzke Heidemann, S.; Kaisenberg, H.K.hling Von; Caliebe, A.; Janssen, D.; Jonat, W.; Grote, W.; Kaisenberg, C.S.V.n 2004: Phenotypical variation in cousins with the identical partial trisomy 9 and 7 at 16 and 23 weeks gestation. American Journal of Medical Genetics 126A(2): 197-203

Ouachee Chardin, M.; Cavazzana Calvo, M.; Blanche, S.; Casanova, J.L.; Hirsch, I.; Caillat Zucman, S.; Fischer, A. 2003: Phenotypically HLA-matched related donor stem cell transplantation in children with inherited diseases A single center Study. Blood 102(11): 477a

Osawa, H.; Yamagami, S.; Tanaka, K.; Yamada, J.; Streilein, J.W. 2000: Phenotypically different T lymphocytes are activated when orthotopic corneal allografts and xenografts are rejected. IOVS Investigative Ophthalmology and Visual Science 41(4): S667

Abdrakhmanova, G.; Vlachova, V.; Vyklicky, L.Jr 2000: Phenotypically induced changes in the properties of glutamate receptors in rat spinal cord motoneurons. Physiological Research 49(4): P25

Crawford, E.; Creswick, H.; Keister, K.L.; Schwartz, S.; Proud, V.K.; Zackowski, J.L. 2003: Phenotypically normal child with a terminal deletion of 3p262. Genetics in Medicine 5(3): 229

Kramer, J.W.; Post, M.A.; Brown, A.M.; Kirsch, G.E. 1999: Phenotypically unique heteromeric channel formed when one Kv61 alpha-subunit coassembles with Kv21. Biophysical Journal 76(1 Part 2): A186

Hu, M.S.; Yeaman, G.; Collins, J.; Debbabi, H.; Kasper, L.H. 1999: Phenotyping and apoptosis of inflammatory cells within eyes of acquired ocular toxoplasmosis in C57BL/6 mice. IOVS Investigative Ophthalmology and Visual Science 40(4): S137

Caron, M.G. 2003: Phenotyping dopamine related behaviors and reward mechanisms in mice. FASEB Journal 17(4-5): Abstract 719

Zarif, L.; Covic, A.; Iyengar, S.; Sedor, J.; Schelling, J. 1999: Phenotyping hypertensive nephrosclerosis Is it really the most common cause of ESRD?. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 93A

Pietrobelli, A.; Miller, S.; Tan, Y.X.; Wang, Z.M.; Nunez, C.; Heymsfield, S.B. 1999: Phenotyping obese subjects Multi-contact electrode bioimpedance system for practical body composition measurement. FASEB Journal 13(4 Part 1): A259

Schrader, M.; Schulte, I.; Appelt, A.; Neitz, S.; Hess, R. 2002: Phenotyping of a diabetes animal model by peptidomics. Molecular and Cellular Proteomics 1(9): 724

Kuhn, I.; Iversen, A.; Bonjoch, X.; Wallis, J.; Ebdon, J.; Taylor, H.; Skraber, S.; Pissarides, N.; Papageorgiou, T.G.; Blanch, A.R. 2003: Phenotyping of bacterial populations A useful method for microbial source tracking. FEMS Congress of European Microbiologists Abstract Book 1: 77

Kerre, T.; De Smet, G.; De Smedt, M.; Offner, F.; Vandekerckhove, B.; Plum, J. 2000: Phenotyping of human spleen and bone marrow homed cells at several timepoints shortly after intravenous injection in Nod/Scid mice. Tissue Antigens 55(Suppl 1): 97-98

Morsy, M.A.; Norman, P.J.; Rela, M.; Heaton, N.D.; Vaughan, R.W. 2002: Phenotyping of intrahepatic T, NKT and NK cells in liver transplant recipients with end-stage alcohol related chronic liver disease. Hepatology 36(4 Part 2): 408A

Morsy, M.A.; Norman, P.J.; Rela, M.; Heaton, N.D.; Vaughan, R.W. 2001: Phenotyping of intrahepatic lymphocytes in human donor liver. Hepatology 34(4 Pt 2): 296A

Friedrich, M.; Krammig, S.; Doecke, W.D.; Sterry, W.; Asadullah, K. 2001: Phenotyping of lesional T-cells in psoriasis by flowcytometry, indicates an activated, memory/effector type 1 immunophenotype. Archives of Dermatological Research 293(1-2): 101

Pearce, D. 2003: Phenotyping of murine bone marrow side population cells. Experimental Hematology (New York) 31(7 Suppl 1): 78

Li, G.; Lambert, C.; Passebosc, K.; Armand, C.; Blanc, F.; Genin, C.; Tostain, J. 1999: Phenotyping of renal cell carcinoma infiltrating lymphocytes. European Urology 36(5): 475

Schulte, I.; Appel, A.; Hess, R.; Schrader, M.; Tammen, H.; Reiter, R. 2003: Phenotyping of the diabetic ob/ob-Mouse model by Peptidomics technologies. Diabetes and Metabolism 29(Hors serie 2): 4S95

Schulte, I.; Appel, A.; Neitz, S.; Hess, R.; Maehnss, K. 2003: Phenotyping of the ob/ob-mouse model by peptidomics. Diabetes 52(Suppl 1): A546

Joshua, D.; Pope, B.; Brown, R.; Brown, L.; Murray, A.; Gibson, J. 2002: Phenotyping primitive plasma cells. British Journal of Haematology 117(1): 252-253

Hemker, H.C.; Béguin, S. 2000: Phenotyping the clotting system. Thrombosis and Haemostasis 84(5): 747-751

Nislow, C.; Adams, C.; Schneiders, E.; Sigal, N.; Oestreicher, D.; Sabry, J.; Drubin, D.G. 2000: Phenotyping yeast using automated image acquisition and analysis on a genome-wide scale. Molecular Biology of the Cell 11(Suppl): 124a-125a

Mokry, J.; Karbanova, J. 2000: Phenotypization of cells yielded from two distinct culture systems for generation of neural progenitor cells. European Journal of Neuroscience 12(Suppl 11): 326

Harfenist, M.; Boros, E.; Heyer, D. 2000: Phenoxathin derivatives as inhibitors of monoamine oxidase. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)

Calderwood, D.J.; Fisher, A.J.; Jeffery, J.E.; Jones, C.G. Pryce; Rafferty, P. 2000: Phenoxy-, phenylthio-, benzoyl-alkyleneaminoalkylene-imidazole derivatives as therapeutic agents. Official Gazette of the United States Patent and Trademark Office Patents 1231(5)

Maroni, M.; Colosio, C.; Ferioli, A.; Fait, A. 2000: Phenoxyacetate herbicides. Toxicology 143(1): 77-83

Tanaka, N.; Tamai, T.; Mukaiyama, H.; Hirabayashi, A.; Muranaka, H.; Sato, M.; Akahane, M. 2003: Phenoxyacetic acid derivatives and medicinal compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)

Tanaka, N.; Goto, R.; Ito, R.; Hayakawa, M.; Sugidachi, A.; Ogawa, T.; Asai, F.; Fujimoto, K. 2000: Phenoxyalkylamines III Synthesis and selective serotonin-2 receptor binding. Chemical and Pharmaceutical Bulletin (tokyo). 48(11): 1729-1739

Frang, H.; Pihlavisto, M.; Cockcroft, V.; Scheinin, M.; Marjamaki, A. 2000: Phenoxybenzamine binds irreversibly to an exposed cysteine in the third transmembrane domain of the human alpha2-adrenoceptor. European Journal of Neuroscience 12(Suppl 11): 403

Adam, M.D.; Andrews, M.D.; Elliott, M.L.; Gymer, G.E.; Hepworth, D.; Howard, H.R. Jr; Middleton, D.S.; Stobie, A. 2003: Phenoxybenzylamine derivatives as SSRIs. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)

Bohn, S.; Bircher, A.J. 2001: Phenoxyethanol-induced urticaria. Allergy 56(9): 922-923

Uckun, F.M.; Venkatachalam, T.K. 2004: Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections. Official Gazette of the United States Patent and Trademark Office Patents 1281(4)

Bigg, D.; Pommier, J.; Martin, C.; Roubert, P.; Defaux, J.P.erre 2003: Phenoxyethylamine derivatives having high affinity for the 5-HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)

Bigg, D.; Galcera, M.O.ile 1999: Phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Cecchi, R.; Croci, T.; Guzzi, U.; Marsault, E. 2003: Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1276(3)

Loughhead, D.G.; Lin, X.F.; Weikert, R.J.; Flippin, L.A. 2000: Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)

Heil, Markus; Meier, Heinrich; Naab, Paul; Voerste, Arnd; De Vry, Jean Marie Viktor; Denzer, Dirk; Mauler, Frank; Lustig, Klemens; Lenfers, Jan Bernd 2004: Phenoxyphenyl alkanesulphonates. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)

Andrews, M.D.; Hepworth, D.; Middleton, D.S.; Stobie, A. 2003: Phenoxyphenylheterocyclyl derivatives as SSRIs. Official Gazette of the United States Patent and Trademark Office Patents 1275(1)

Nishiyama, A.; Bougauchi, M.; Kuroita, T.; Minoguchi, M.; Morio, Y.; Kanzaki, K. 2004: Phenoxypropylamine compounds. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Dorn-Beineke, A.; Hassan, A.-W.; Bräutigam, J.; Hildenbrand, R.; Dempfle, C.-E.; Schwab, M. 2003: Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapy. Thrombosis and Haemostasis 90(6): 1210-1213

Bux-Gewehr, I.; Zotz, R.B.; Scharf, R.E. 2000: Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorder. Thrombosis and Haemostasis 83(5): 799-800

Sorbera, L.A.; Castaner, J. 2003: Phenserine tartrate Treatment of alzheimers disease. Drugs of the Future 28(1): 18-25

Gorbenko, N.; Poltorak, V.; Gladkih, A. 2003: Phensuccinal improves beta-cell function in streptozotocin-treated newborn rats. Diabetes and Metabolism 29(Hors serie 2): 4S267

Gorbenko, N.; Poltorak, V.; Gladkich, A.; Leshchenko, Z.; Pivovarevich, L. 2001: Phensuccinal improves lipid profile and enhances paraoxonase activity in diabetic rabbits. Diabetologia 44(Suppl 1): A322

Maher, T.J.; Ulus, I.H.; Wurtman, R.J. 1999: Phentermine and other monoamine-oxidase inhibitors may increase plasma serotonin when given with fenfluramines. Lancet 353(9146): 38

Maher, T.J. 2000: Phentermine's effect on serotonin in plasma?. American Journal of Cardiology 86(7): 810-811

Burns, M.; Dickson, E.; Sivilotti, M.; Cuenoud, H. 1999: Phentolamine antagonism of phenylpropanolamine-induced mortality. Journal of Toxicology. Clinical Toxicology 37(5): 630

Kooijman, M.; Rongen, G.A.; Smits, P.; Hopman, M.T.E. 2002: Phentolamine as a tool to study the contribution of alpha-adrenoceptor stimulation to basal thigh vascular tone. Medicine and Science in Sports and Exercise 34(5 Suppl): S30

Hoffman, R.P.; Dopp, J.M.; Sinkey, C.A.; Phillips, B.G. 2001: Phentolamine augments hyperinsulinemic vasodilation but does not alter muscular glucose uptake. Diabetes 50(Suppl 2): A328

Hoy, M.; Bokvist, K.; Weng, X.G.; Hansen, J.; Buschard, K.; Gromada, J. 2000: Phentolamine inhibits exocytosis by G12 protein-dependent activation of calcineurin in rat pancreatic A-cells. Diabetologia 43(Suppl 1): A118

Hatzichristou, D.G.; Apostolidis, A.; Tzortzis, V.; Hatzimouratidis, K.; Kouvelas, D. 2001: Phentolamine mesylate administered per os, enhances nocturnal erectile activity. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R133

Reinke, L.A.; Moore, D.R.; Sang, H.; Janzen, E.G.; Kotake, Y. 1999: Phenyl N-t-butylnitrone hydroxylation by cytochrome P-450 and hydroxyl radicals. Free Radical Biology and Medicine 27(Suppl 1): S133

Kotake, Y.; Sang, H.; Wallis, G.L.; Stewart, C.A. 1999: Phenyl N-tert-butylnitrone provides protection from endotoxin shock through amplified production of the anti-inflammatory cytokine interleukin-10. Archives of Biochemistry and Biophysics 371(1): 129-131

Goodson, T., J.; Harper, R.W.; Herron, D.K. 2002: Phenyl acetamides as sPLA2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1256(1)

Ziegler, H.; Trah, S.; Farooq, S.; Zurfluh, R. 2001: Phenyl acetic acid derivatives as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1252(1)

Fobare, W.F.; Freymuller, J. 2002: Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Official Gazette of the United States Patent and Trademark Office Patents 1258(4)

Bromidge, S.M.; Clarke, S.E.; Gager, T.; Griffith, K.; Jeffrey, P.; Jennings, A.J.; Joiner, G.F.; King, F.D.; Lovell, P.J.; Moss, S.F.; Newman, H.; Riley, G.; Rogers, D.; Routledge, C.; Serafinowska, H.; Smith, D.R. 2001: Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists Identification of N- -4-methoxy-3-piperazin-1-ylbenzenesulfonamide. Bioorganic and Medicinal Chemistry Letters 11(1): 55-58, 8 January

Christophersen, P.; Pedersen, O. 2002: Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers. Official Gazette of the United States Patent and Trademark Office Patents 1260(2)

Xiang, J.N.; Macpherson, D.T.; Corbett, D.F.; Elliott, J.D. 2000: Phenyl derivatives useful as endothelin receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)

Goodson, T., J.; Harper, R.W.; Herron, D.K. 1999: Phenyl glyoxamides as SPLA2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1223(5)

Andersson, P.G.; Hedberg, C. 2004: Phenyl inden-1-one compounds. Official Gazette of the United States Patent and Trademark Office Patents 1286(2)

Lai, C.S.; Tiekink, E.R.T. 2003: Phenyl mercury. Applied Organometallic Chemistry 17(3): 194

Malamas, M.S.; Wrobel, J.E.; Dietrich, A.J.; Li, Z.; Gunawan, I. 2000: Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)

Nargund, R.; Barakat, K.; Rohrer, S.; Birzin, E.; Mellin, T.; Cashen, D.; Jacks, T.; Schleim, K.; Mosley, R.; Hickey, G.; Schaeffer, J.; Patchett, A. 2000: Phenyl piperidine-based orally active peptidomimetic agonists for somatostatin receptor subtype-2. Fields, Gregg B Author, Tam, James P Author, Barany, George Author Peptides for the new millennium 248-249

Andersson, P.G.; Hedberg, C. 2004: Phenyl propenone compounds. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)

Caldwell, C.G.; Chiang, Y C.; Dorn, C.; Finke, P.; Hale, J.; Maccoss, M.; Mills, S.; Robichaud, A. 1999: Phenyl spiroethercycloalkyl tachykinin receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 545-546

Hahin, R.; Kondratiev, A. 1999: Phenyl substituted n-alkanols reduce Na currents by blocking, inactivating, and altering channel kinetics. Society for Neuroscience Abstracts 25(1-2): 1253

Bos, M.A.; Galley, G.; Godel, T.; Hoffmann, T.; Hunkeler, W.; Schnider, P.; Stadler, H. 2002: Phenyl substituted pyridine and benzene derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)

Koizumi, N.; Okada, M.; Iwashita, S.; Takegawa, S.; Nakagawa, T.; Takahashi, H.; Fujii, T. 2004: Phenyl sulfamate derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1284(2)

Murugesan, N.; Hunt, J.T. 2000: Phenyl sulfonamide endothelin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)

Chan, G.L.; Johns, A.; Jurewicz, A.J.; Porter, R.A.; Widdowson, K.L. 2002: Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)

Coulton, S.; Johns, A.; Porter, R.A.an 2004: Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)

Widdowson, K.L.; Veber, D.F.; Jurewicz, A.J.; Hertzberg, R.P.; Rutledge, M.C., J. 2001: Phenyl urea antagonists of the IL-8 receptor. Official Gazette of the United States Patent and Trademark Office Patents 1245(1)

Baroni, M.; Bourrie, B.; Cardamone, R.; Casellas, P.; Guzzi, U. 2003: Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)

Belley, M.; Gauthier, J.Y.; Grimm, E.; Leblanc, Y.; Li, C.S.; Therien, M.; Black, C.; Prasit, P.; Lau, C.K.; Roy, P. 1999: Phenyl-2- -furanones as COX-2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)

Leblanc, Y.; Roy, P.; Leger, S.; Grimm, E.; Wang, Z. 2000: Phenyl-2- -furanones with oxygen link as COX-2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Fuchs, K.; Stransky, W.; Grauert, M.; Carter, A.; Gaida, W.; Weiser, T.; Ensinger, H. 2004: Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines. Official Gazette of the United States Patent and Trademark Office Patents 1285(1)

Pruitt, J.R.; Fevig, J.M.; Quan, M.L.; Pinto, D.J. Phillip 2001: Phenyl-isoxazoles as factor XA Inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)

Hull, K.G.; Sidduri, A.; Tilley, J.W. 2002: Phenyl-keto-imidazolidine thioamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)

Xi, N.; Xu, S.; Zhu, J.; Arvedson, S.; Zhang, J.; Osslund, T.; Dominguez, C. 2001: Phenyl-lactam structure as mimetic of peptide turn. Abstracts of Papers American Chemical Society 221(1-2): ORGN 80

Ziegler, H.; Zurfluh, R. 2002: Phenyl-methoxyimino-glyoxylic acid derivatives as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Hendricks, M L.; Van, D., G.C.E.; Van, D., P.J.V.; Van, D., G.K.L.; Ndrebosmans, J P.R.; Verdonck, M.G.C. 1999: Phenyl-oxo-alkyl- benzoate derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2523-2524

Coghlan, R.D.; Fobare, W.F. 2003: Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)

Meier, Heinrich; Hartwig, Wolfgang; Junge, Bodo; Schohe Loop, Rudolf; Gao, Zhan; Schmidt, Bernard; De Jonge, Maarten; Schuurman, Teunis 2001: Phenyl-substituted 1,4-dihydropyridines. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)

Adam, G.; Kolczewski, S.; Mutel, V.; Wichmann, J.; Woltering, T.J.hannes 1999: Phenyl-substituted 5H-thiazolo pyrimidine derivative glutamate receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)

Schwark, J.R.; Kleemann, H.W.; Lang, H.J.; Weichert, A.; Scholz, W.; Albus, U. 2000: Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them. Official Gazette of the United States Patent and Trademark Office Patents 1231(3)

Schwark, J.R.; Brendel, J.; Kleemann, H.W.; Lang, H.J.; Weichert, A.; Jansen, H.W.; Scholz, W. 1999: Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them. Official Gazette of the United States Patent and Trademark Office Patents 1229(3)

Afonso, A.; Kelly, J.M.; Weinstein, J.; Wolin, R.L.; Rosenblum, S.B. 2001: Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase. Official Gazette of the United States Patent and Trademark Office Patents 1245(3)

Cavalla, D.J.; Chasin, M.; Dolby, L.J.; Frith, R.W. 2001: Phenyl-triazole compounds for PDE-IV inhibition. Official Gazette of the United States Patent and Trademark Office Patents 1247(3)

Park, N.S.; Jung, Y.S.; Seong, C.M.; Choi, S.W.; Choi, Y.J.; Lee, J.C.; Choi, J.I.; Lee, K.S.; Kong, J.Y.; Lee, B.Y.; Kim, J.H. 1999: Phenylacetamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)

Pevarello, P.; Orsini, P.; Traquandi, G.; Brasca, M.G.; Amici, R.; Villa, M.; Piutti, C.; Varasi, M.; Longo, A. 2002: Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents. Official Gazette of the United States Patent and Trademark Office Patents 1262(4)

Protiva, P.; Agarwal, B.; Holt, P.R. 2001: Phenylacetate enhances the effect of chemotherapy on colon cancer cells. Gastroenterology 120(5 Suppl 1): A 616

Waldbillig, R.J.; Mrowczynski, E.; Burzynski, S. 2003: Phenylacetic acid and phenylacetylglutamine Mechanism of uptake and changes in epigenetic-mechanisms regulating gene expression. Cancer Epidemiology Biomarkers and Prevention 12(11 Part 2): 1289s-1290s

Grell, W.; Hurnaus, R.; Sauter, R.; Reiffen, M.; Rupprecht, E. 2000: Phenylacetic acid benzylamides. Official Gazette of the United States Patent and Trademark Office Patents 1240(1)

Burzynski, S.R. 2000: Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)

Bayer, H.; Sauter, H.; Mueller, R.; Grammenos, W.; Harreus, A.; Kirstgen, R.; Roehl, F.; Ammermann, E.; Lorenz, G. 1999: Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them. Official Gazette of the United States Patent and Trademark Office Patents 1220(5): 4606-4607

Bayer, H.; Sauter, H.; Oberdorf, K.; Grammenos, W.; Grote, T.; Kirstgen, R.; Muller, B.; Muller, R.; Rohl, F.; Ammermann, E.; Harries, V.; Lorenz, G.; Strathmann, S.; Gotz, N.; Harreus, A. 2003: Phenylacetic acid derivatives, process and intermediate products for their preparation, and their use as fungicides and pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)

Muller, B.; Sauter, H.; Bayer, H.; Grammenos, W.; Grote, T.; Kirstgen, R.; Oberdorf, K.; Rohl, F.; Gotz, N.; Rack, M.; Muller, R.; Lorenz, G.; Ammermann, E.; Strathmann, S.; Harries, V. 2001: Phenylacetic acid derivatives, process for their preparation and their use as pesticides and fungicides. Official Gazette of the United States Patent and Trademark Office Patents 1248(4)

Grote, T.; Bayer, H.; Muller, R.; Sauter, H.; Kirstgen, R.; Harries, V.; Lorenz, G.; Ammermann, E.; Strathmann, S. 2000: Phenylacetic acid derivatives, processes and intermediates for their preparation, and compositions comprising them. Official Gazette of the United States Patent and Trademark Office Patents 1232(2)

Grote, T.; Bayer, H.; Muller, R.; Sauter, H.; Kirstgen, R.; Harries, V.; Lorenz, G.; Ammermann, E.; Strathmann, S. 1999: Phenylacetic acid derivatives, processes and intermediates for use in producing them and agents containing them. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)

Heil, M.; Militzer, H.C.; Bretschneider, T.; Alig, B.; Mauler Machnik, A.; Stenzel, K.; Wachendorff Neumann, U. 2002: Phenylacetic acid heterocyclyl amides having an insecticidal effect. Official Gazette of the United States Patent and Trademark Office Patents 1259(2)

Liang, C.D.; Mckearn, J.P.; Farah, J.M.Jr; Mueller, R.A. 2002: Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Gledhill, L.; Greaves, P.A.; Griffin, J.P. 2001: Phenylacetyl-CoA ligase from penicillium chrysogenum. Official Gazette of the United States Patent and Trademark Office Patents 1247(2)

Fukumoto, K.; Kohno, S.; Kanoh, K.; Asari, T.; Kawashima, H.; Sekiya, H.; Ohmizo, K.; Harada, T. 2002: Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)

Kanoh, K.; Kohno, S.; Katada, J.; Takahashi, J.; Uno, I. 1999: (-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization. Journal of Antibiotics 52(2): 134-141

Parales, R.E.; Lee, K.; Resnick, S.M.; Gibson, D.T. 1999: Phenylalanine 352 controls the regioselectivity and enantioselectivity of cis-dihydroxylation reactions catalyzed by naphthalene dioxygenase. Abstracts of the General Meeting of the American Society for Microbiology 99: 579

Yoshida, R.K.; Kootstra, A.B. 2002: Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)

Head, J.C.; Porter, J.R.; Warrellow, G.J.; Archibald, S.C.; Hutchinson, B.W. 2004: Phenylalanine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1278(2)

Konradi, A.W.; Pleiss, M.A.; Thorsett, E.D.; Ashwell, S.; Welmaker, G.S.; Kreft, A.; Sarantakis, D.; Dressen, D.B.; Grant, F.S.; Semko, C.; Xu, Y.Z. 2004: Phenylalanine derivatives as alpha 4 integrin inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)

Hainline, B.E. 1999: Phenylalanine free protein. Official Gazette of the United States Patent and Trademark Office Patents 1229(3)

Richardson, Mary Ann 2001: Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)

Gianni, M.L.; Fiori, L.; Lammardo, A.M.; Fiege, B.; Verduci, E.; Racchi, E.; Rossi, S.; Giovannini, M. 2001: Phenylalanine hydroxylase mutations and phenylalanine-tyrosine metabolism in heterozygotes for phenylketonuria. Journal of Inherited Metabolic Disease 24(Suppl 1): 25

Huijbregts, S.C.J.; De Sonneville, L.M.J.; Licht, R.; Van Spronsen, F.J.; Sergeant, J.A. 2001: Phenylalanine levels between ages 25 and 7 predict neuropsychological outcome between ages 7 and 14 in treated phenylketonuria. Journal of Inherited Metabolic Disease 24(Suppl 1): 15

Ravi, S.; Lu, N.C.; Belo, P.; Sucher, K. 2002: Phenylalanine requirement and its biosynthesis in C elegans. FASEB Journal 16(4): A259

Courtney Martin, G.; Rafii, M.; Ball, R.O.; Clarke, J.T.R.; Bross, R.; Pencharz, P.B. 1999: Phenylalanine requirement in children with classical phenylketonuria. FASEB Journal 13(4 Part 1): A568

Ost, T.W.B.; Miles, C.S.; Munro, A.W.; Reid, G.A.; Chapman, S.K. 2001: Phenylalanine-393 Controlling the electronic properties of the heme in flavocytochrome P450 BM3. Biochemical Society Transactions 29(1): A37

Bula, C.M.; Bishop, J.E.; Norman, A.W. 2003: Phenylalanine-406 may act to stabilize the open conformation of the nuclear vitamin D receptor. FASEB Journal 17(4-5): Abstract 652

Harriman, G.; Schwender, C.; Gallant, D.; Cochran, N.; Briskin, M. 1999: Phenylalanine-based integrin-cell adhesion molecule antagonists. Abstracts of Papers American Chemical Society 218(1-2): MEDI 64

Carr, N.G.; Mann, N.H. 2002: Phenylalanine-free protein and DNA coding therefor. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)

Sidduri, A.; Tilley, J.W.ight 2002: Phenylalaninol derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1260(3)

Jaworski, D.D.; Lawlor, E.J.; Wang, M. 1999: Phenylalanyl tRNA synthetase alpha subunit polynucleotides from Streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2482

Jaworski, D.D.; Lawlor, E.J.; Wang, M. 2000: Phenylalanyl tRNA synthetase from streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)

Lawlor, Elizabeth Jane 2001: Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)

Hodgson, J.E.; Lawlor, E.J. 1999: Phenylalanyl-tRNA synthetase from Staphylococcus aureus. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)

Konno, M.; Nakae, T.; Hamanaka, N. 1999: Phenylalkan oic acid. Official Gazette of the United States Patent and Trademark Office Patents 1229(2)

Masuda, K.; Urushibata, I.; Asahara, T.; Furuse, K.; Kojima, Y.; Abe, H. 2000: Phenylalkane amide derivatives and agricultural or horticultural fungicides. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)

Porter, J.R.; Warrellow, G.J.; Archibald, S.C.; Head, J.C. 2003: Phenylalkanoic acid derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1268(3)

Kim, Y.K.; Seo, S.Y.; Heo, J.; Choi, Y.M. 2003: Phenylalkyl diamine as sigma receptor ligands Structure-activity relationship and potential anti-depressant activity. Abstracts of Papers American Chemical Society 226(1-2): MEDI 152

Cardinal, H.; Virdis, A.; Ghiadoni, L.; Haq, B.A.; Taddei, S.; Salvetti, G.; Salvetti, A. 2000: Phenylalkylamine calcium antagonist improves endothelium-dependent vasodilation by restoring nitric oxide availability in essential hypertensive patients. American Journal of Hypertension 13(4 Part 2): 242A

Huber, I.G.; Sinnegger, M.J.; Koschak, A.; Waldschuetz, R.; Pongs, O.; Striessnig, J. 2002: Phenylalkylamine interaction with transmembrane segment IIIS5 of L-type Ca2+ channel alpha1C subunits. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R58

Choi, Y.M.; Byun, J.K. 1999: Phenylalkylaminoalcohol carbamates and process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)

Yanagisawa, H.; Takamura, M.; Fujita, T.; Fujiwara, T. 2000: Phenylalkylcarboxylic acid compounds and compositions for treating hyperglycemia. Official Gazette of the United States Patent and Trademark Office Patents 1237(3)

Anderskewitz, R.; Schromm, K.; Renth, E.O.; Birke, F.; Jennewein, H.M.; Meade, C.J. Montague; Ding, A. 2000: Phenylamidine derivatives, a process for preparing the same and their use as medicaments. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)

Tanaka, K.; Nishida, T.; Nakano, J.; Inoue, M.; Nakamura, T.; Debuchi, H. 2000: Phenylamidinothiophene derivatives and anti-inflammatory agent containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1233(2)

Tamai, T.; Tanaka, N.; Mukaiyama, H.; Hirabayashi, A.; Muranaka, H.; Sato, M.; Akahane, M. 2002: Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same. Official Gazette of the United States Patent and Trademark Office Patents 1256(1)

Beeley, N.R.bert Arnold; Millican, T.A.drew 2000: Phenylaminocarbonyl derivatives and processes for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)

Sahara, N.; Takeshita, A.; Kobayashi, M.; Shigeno, K.; Nakamura, S.; Shinjo, K.; Naito, K.; Ohnishi, K.; Naoe, T.; Ohno, R. 2002: Phenylarsine Oxide More Intensely Induces Apoptosis in ATRA- and As2O3-Resistant APL Cell Lines Than As2O3 by Activating the Mitochondrial Pathway. Blood 100(11): Abstract No. 2134

Gerhard, R.; Just, I.; John, H. 2002: Phenylarsine oxide crosslinks cysteine residues within the GTP-binding region of the RhoA GTPase. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R147

Takahashi, H.; Suzuki, K.; Namiki, H. 2002: Phenylarsine oxide induces reverse translocation of PMA-activated PKCbetaII. Zoological Science 19(12): 1436

Umeda, N.; Mochizuki, N.; Uchida, S.; Nishibe, T.; Yamada, H.; Ito, K.; Horikoshi, H. 2002: Phenylazole compounds, process for producing the same and drugs for hyperlipemia. Official Gazette of the United States Patent and Trademark Office Patents 1254(5)

Harrison, T.; Sparey, T.J.; Teall, M.R. 2000: Phenylbenzimidazole derivatives as ligands for GABA receptors. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Stolowitz, M.L. 1999: Phenylboronic acid complexing reagents derived from aminosalicylic acid. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)

Green, G. 2003: Phenylbutazone carrier formulation. Official Gazette of the United States Patent and Trademark Office Patents 1269(4)

Pastor, J.; Zamarron, E.; Marinero, P.; Del Nozal, M.; Carrasco, B.; De La Rua, E. 1999: Phenylbutazone solved in silicone oil reduces lipid peroxidation from retina and lens in rabbits. IOVS Investigative Ophthalmology and Visual Science 40(4): S869

Clarke, K.; Feinman, R.; Harrison, L.E. 2001: Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB. Proceedings of the American Association for Cancer Research Annual Meeting 42: 636

Terni, P.; Mairani, L.; Mandelli, G.; Pagella, P.G.; Marchesini, D.; Mariorana, S.; Brufani, M. 1999: Phenylcarbamate derivatives suitable to the use as anticholinesterase substances. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1584

Brossi, A.; Brzostowska, M.; Rapoport, S.; Greig, N. 1999: Phenylcarbamates of -eseroline, -N1-noreseroline and -N1-benzylnoreseroline selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Bayer, H.; Muller, B.; Muller, R.; Sauter, H.; Grote, T.; Grammenos, W.; Kirstgen, R.; Oberdorf, K.; Ptock, A.; Gotz, N.; Rack, M.; Rohl, F.; Ammermann, E.; Harries, V.; Lorenz, G.; Strathmann, S. 2000: Phenylcarbamates, methods for preparing them and agents containing them. Official Gazette of the United States Patent and Trademark Office Patents 1239(2)

Muller, B.; Sauter, H.; Bayer, H.; Grammenos, W.; Grote, T.; Kirstgen, R.; Oberdorf, K.; Rohl, F.; Gotz, N.; Rack, M.; Muller, R.; Lorenz, G.; Ammermann, E.; Strathmann, S.; Harries, V. 2000: Phenylcarbamates, processes and intermediate products for their preparation and their use as pesticides and fungicides. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)

Karamloo, F.; Lewis, N.G.; Wangorsch, A.; Haustein, D.; Vieths, S. 2001: Phenylcoumaran benzylic ether reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Journal of Allergy and Clinical Immunology 107(2): S185

Stolowitz, M.L.; Kesicki, E.A.; Lund, K.P.; Hughes, K.A. 2002: Phenyldiboronic acid reagents and complexes. Official Gazette of the United States Patent and Trademark Office Patents 1263(2)

Ulrich, Wolf Rudiger 1999: Phenyldihydrobenzofuranes. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)

Tewari, N.; Ramesh; Gupta, S.; Tripathi, R.P. 2003: Phenylene bridged bis-glycosyl ureides as potential antileishmanial agents. Medicinal Chemistry Research 12(6-7): 314-315

Arnt, L.; Tew, G.N. 2002: Phenylene ethynylene polymers with amphiphilic structures. Abstracts of Papers American Chemical Society 224(1-2): POLY 559

Nishino, C.; Adachi, K.; Miyazawa, K.; Inada, R.; Otake, T. 2000: Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Keys, J.R.; Koch, W.J.; Eckhart, A.D. 2001: Phenylephrine -induced cardiac hypertrophy is mediated by the vascular system. FASEB Journal 15(4): A481

Kawabe, T.; Hu, J.; Harris, P.D.; Garrison, R.N.al 2001: Phenylephrine -induced vessel contraction is enhanced by PE-released constrictor prostanoid. FASEB Journal 15(4): A113

Zhao, N.; Ingenito, S.; Sica, A.L.; Gootman, P.M. 2002: Phenylephrine evoked dysrhythmias in developing swine with surgically-induced asymmetric autonomic cardiac innervation. FASEB Journal 16(4): A119

Xiao, Y.hui; Zhang, Lubo 2003: Phenylephrine induces apoptosis in cultured bovine endocardial endothelial cells role of c-myc and bcl-2. FASEB Journal 17(4-5): Abstract 412

Boer, Christa; Scheffer, Gert Jan; De Lange, Jaap J.; Westerhof, Nico; Sipkema, Peter 1999: Phenylephrine induces nitric oxide release in rat pulmonary arteries. FASEB Journal 13(4 Part 1): A100

Ikeda, T.; Ozaki, M.; Ikeda, K.; Sessler, D.I.; Sato, S. 1999: Phenylephrine infusion decreases the magnitude of redistribution hypothermia. Anesthesiology 91(3A): A523

Shapira, Y.; Talmor, D.; Merkind, V.; Artru, A.A.; Shapiro, O. 1999: Phenylephrine or large volume of saline given IV worsens outcome in a rat model of closed head trauma combined with uncontrolled hemorrhage. Anesthesiology 91(3A): A829

Davies, A.; Taylor, P.M.; Proud, C.G. 2000: Phenylephrine stimulation of growth in adult cardiomyocytes is dependent upon p38 MAP kinase. FASEB Journal 14(4): A583

Nash, P.J.; Stewart, W.J. 2002: Phenylephrine stress echocardiography A new pharmacologic test to evaluate mitral regurgitation. Journal of the American College of Cardiology 39(5 Suppl A): 371A

Acosta, F.; Sansano, T.; Contreras, R.F.; Reche, M.; Roques, V.; Beltran, R.; Rodriguez, M.A.; Robles, R.; Bueno, F.S.; Ramirez, P.; Parrilla, P. 1999: Phenylephrine treatment of the postreperfusion syndrome in liver transplantation. Transplantation Proceedings 31(6): 2373-2374

Kawabe, T.; Harris, P.D.; Garrison, R.N.al 2000: Phenylephrine triggers induction of agents to blunt vascular reactivity and contraction over time. FASEB Journal 14(4): A416

Kawabe, T.; Beach, K.P.; Harris, P.D.; Spain, D.A.; Garrison, R.N. 2000: Phenylephrine-induced contraction is limited by NOS1+3 and NOS2 at low and high preloads. FASEB Journal 14(4): A416

Cui, J.; Wilson, T.E.; Crandall, C.G. 2002: Phenylephrine-induced elevations in blood pressure is attenuated in heat stressed humans. Medicine and Science in Sports and Exercise 34(5 Suppl): S59

Stocker, S.D.; Schiltz, J.C.; Stricker, E.M.; Sved, A.F. 2000: Phenylephrine-induced increases in arterial blood pressure inhibit thirst but not vasopressin secretion in rats. FASEB Journal 14(4): A371

Saeed, A.E.; Parmentier, J.H.; Malik, K.U. 2001: Phenylephrine-induced inhibition of cell proliferation is mediated by a mechanism independent of cyclic AMP in rat-1 fibroblasts expressing alpha-1 adrenergic receptors. FASEB Journal 15(4): A565

Olivier,D.K.; Shikanga,E.A.; Combrinck,S.; Krause,R.W.M.; Regnier,T.; Dlamini,T.P. 2010: Phenylethanoid glycosides from Lippia javanica. South African Journal Of Botany: 1, 58-63

Freeman, J.G.; Ryan, J.J.; Hu Li, J.; Stewart, J.K. 1999: Phenylethanolamine N-methyl transferase mRNA in lymphoid cells. FASEB Journal 13(4 Part 1): A57

Tai, T.-C.; Wong, D.L. 2002: Phenylethanolamine N-methyltransferase gene regulation by cAMP-dependent protein kinase a and protein kinase C signaling pathways. Annals of the new York Academy of Sciences 971: 83-85

Kitazawa, M.; Okazaki, K.; Tamai, T.; Saito, M.; Tanaka, N.; Kobayashi, H.; Kikuchi, K.; Muranaka, H. 2000: Phenylethanolaminotetralincarboxamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1233(1)

Chorev, M.; Goren, T.; Herzig, Y.; Sterling, J.; Weinstock Rosin, M.; Youdim, M.B.H. 2001: Phenylethylamine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1247(4)

Anderskewitz, R.; Birke, F.; Jennewein, H.M. 2000: Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1239(3)

Wikstrom, H.; Dijkstra, D.; Venhuis, B.J.han 2004: Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)

Mutel, V.; Peters, J.U.; Wichmann, J. 2004: Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles. Official Gazette of the United States Patent and Trademark Office Patents 1280(3)

Baker, S.R.; Clark, B.P.; Goldsworthy, J.; Harris, J.R. 1999: Phenylglycine derivatives useful for treating disorders of the central nervous system. Official Gazette of the United States Patent and Trademark Office Patents 1218(4): 3140-3141

Claussner, A.; Goubet, F.; Teutsch, J.G.orges 2001: Phenylimidazolidines containing nitrooxy or carbonyloxy groups. Official Gazette of the United States Patent and Trademark Office Patents 1247(1)

Castro Pineiro, J.L.; Hutchins, S.M.; Lewis, S.J.; Rowley, M.; Smith, A.L.; Stevenson, G.I. 2002: Phenylindole derivatives as 5-HT2A receptor ligands. Official Gazette of the United States Patent and Trademark Office Patents 1264(4)

Lacolla, P.; Artico, M.; Sommadossi, J.P.erre 2004: Phenylindoles for the treatment of HIV. Official Gazette of the United States Patent and Trademark Office Patents 1280(4)

Quideau, S.; Pouysegu, L.; Oxoby, M.; Looney, M.A. 2001: Phenyliodine -mediated oxidative activation of 2-alkoxyarenols for carbon-oxygen, carbon-nitrogen and carbon-carbon bond formations. Abstracts of Papers American Chemical Society 221(1-2): ORGN 640

Olivera, R.; Sanmartin, R.; Pascual, S.; Herrero, M.; Dominguez, E. 1999: Phenyliodine bis mediated synthesis of phenanthro fused isoxazoles and pyrimidines. Tetrahedron Letters 40(17): 3479-3480

Grammenos, W.; Sauter, H.; Bayer, H.; Grote, T.; Gypser, A.; Kirstgen, R.; Muller, B.; Ptock, A.; Rohl, F.; Gotz, R.; Lorenz, G.; Ammermann, E.; Strathmann, S.; Harries, V. 2001: Phenylketiminooxybenzyl compounds, method for the production and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)

Cederbaum, S. 2002: Phenylketonuria: an update. Current Opinion in Pediatrics 14(6): 702-706

Weglage, J.; Grenzebach, M.; Denecke, J.; Koch, H.G.; Feldmann, R. 2002: Phenylketonuria Early treated young adults are not able to estimate their blood phenylalanine levels accurately. Journal of Inherited Metabolic Disease 25(Suppl 1): 9

Perez, B.; Pey, A.; Gamez, A.; Desviat, L.R.; Ugarte, M. 2001: Phenylketonuria Genotype-phenotype correlations based on expressed activity of 18 mutant proteins. American Journal of Human Genetics 69(4 Suppl): 480

Cerone, R.; Schiaffino, M.; Gianotti, D.; Veneselli, E.; Lorini, R. 2000: Phenylketonuria Is diet for life necessary?. Journal of Inherited Metabolic Disease 23(Suppl 1): 33

Walter, J.H.; White, F.J.; Hall, S.K.; Macdonald, A.; Rylance, G.; Boneh, A.; Francis, D.E.; Shortland, G.J.; Schmidt, M.; Vail, A. 2002: Phenylketonuria Is it possible to comply with current recommendations for dietary control? An audit from 4 major regional centres. Lancet (North American Edition) 360(9326): 55-57

Feldman, R.; Denecke, J.; Pietsch, M.; Grenzebach, M.; Weglage, J. 2001: Phenylketonuria No long term frontal lobe dependent deficits of early treated patients in comparison to diabetic patients. Journal of Inherited Metabolic Disease 24(Suppl 1): 17

Feldmann, R.; Denecke, J.; Pietsch, M.; Grenzebach, M.; Weglage, J. 2000: Phenylketonuria No specific frontal lobe dependent deficits of early treated patients in comparison to diabetic patients. Journal of Inherited Metabolic Disease 23(Suppl 1): 26

Maximova, S.P.; Mkheidze, M.O. 2001: Phenylketonuria Thirty years of observation in St Petersburg. Journal of Inherited Metabolic Disease 24(Suppl 1): 3

Stern, A.; Moseley, K. 2002: Phenylketonuria and IQ How many IQ points do we really need? Mental testing issues in treated PKU adults for future research. Journal of Inherited Metabolic Disease 25(Suppl 1): 9

Kalkanoğlu, H.S.; Anadol, D.; Yilmaz, E.; Coşkun, T. 2000: Phenylketonuria and cystic fibrosis in the same patient. Pediatrics International: Official Journal of the Japan Pediatric Society 42(1): 92-93

Bessman, S.P. 2001: Phenylketonuria heterozygosity as a cause of non-specific mental retardation. Pediatric Research 49(4 Part 2): 393A

Vallian, S.; Barahimi, E.; Shamoradgoli, M.; Hosseini, M.; Moeini, H. 2002: Phenylketonuria in Iran, the first report from the historical city of Isfahan. European Journal of Human Genetics 10(Suppl 1): 204

Hutchinson, D.K.; Brickner, S.J.; Barbachyn, M.R.; Taniguchi, M.; Munesada, K.; Yamada, H. 1999: Phenyloxazolidinone antimicrobials. Official Gazette of the United States Patent and Trademark Office Patents 1220(3): 2564-2565

Thomas, R.C.; Poel, T.J.; Barbachyn, M.R. 1999: Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)

Thomas, R.C.; Poel, T.J. 2002: Phenyloxazolidinones having a c-c bond 4-8 membered heterocyclic rings. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)

Gutterer, B. 2002: Phenylphennanthridines with PDE-IV inhibiting activity. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)

Ajito, K.; Murakami, S.; Ishikawa, M.; Yamamoto, M.; Kubota, D.; Gomi, S.; Hachisu, M.; Katano, K. 2002: Phenylpiperazine derivatives as integrin alphavbeta3 antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Vogt, T. 2010: Phenylpropanoid biosynthesis. Molecular Plant 3(1): 2-20

Solecka, D.; Kacperska, A. 2000: Phenylpropanoids and acclimation of winter oilseed rape plants to low temperature. Plant Physiology and Biochemistry 38: s174

Kim, S.R.; Lee, M.K.; Kim, Y.C.; Markelonis, G.J.; Oh, T.H. 1999: Phenylpropanoids from Scrophularia buergeriana protect cultured rat cortical neurons from glutamate-induced neurodegeneration. Society for Neuroscience Abstracts 25(1-2): 576

Phillips, C.V.; Goodman, K.J. 2001: Phenylpropanolamine banned based on what?. American Journal of Epidemiology 153(11 Suppl): S99

Matier, W.L.; Patil, S. 2001: Phenylpropionic acids and esters compounds and methods for inducing beta-blockade for the treatment of cardiac disorders. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)

Ohkuchi, M.; Kyotani, Y.; Shigyo, H.; Koshi, T.; Ohgiya, T.; Matsuda, T.; Kumai, N.; Kotaki, K. 2003: Phenylpyridazine compounds and medicines containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)

Manley, P.W. 2000: Phenylpyridine derivatives useful as phosphodiesterase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1236(3)

Rho, M-Chual.; Lee, H.Sun.; Chang, K-Tae.; Song, H.Young.; Kwon, O.Eok.; Lee, S.Woong.; Ko, J.Suk.; Hong, S.Gyu.; Kim, Y-Kook. 2002: Phenylpyropene C, a new inhibitor of acyl-CoA: cholesterol acyltransferase produced by Penicillium griseofulvum F1959. Journal of Antibiotics 55(2): 211-214

Kelly, T.A.; Bormann, B.J.; Frye, L.L.; Wu, J.P. 2002: Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)

Agostinelli, Enzo; Turini, Paola; Befani, Olivia; Martone, Alessandro; Di Santo, Roberto; Costi, Roberta; Artico, Marino; Roux, Alessandra; La Torre, Francesco; Ferretti, Rossella; Gallinella, Bruno; Cirilli, Roberto 2003: Phenylpyrrolylethanoneamines related to kathinone, endowed with potent and highly selective anti-MAO-A activity. Amino Acids 25(2): 113

Carpy, A.J.M.; Haasbroek, P.P.; Oliver, D.W. 2003: Phenylpyruvic acid derivatives as enzyme inhibitors Therapeutic potential on MIF. Medicinal Chemistry Research 12(4-5): 163-164

Vaupel, A. 2003: Phenylserine derivatives as integrin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)

Panzeri, Achille; Nesi, Marcella; Di Salle, Enrico 1999: Phenylsubstituted 4-azasteroid fluoroderivatives. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)

Romero, A.G.; Leiby, J.A. 2000: Phenylsulfonamide-phenylethylamines useful as dopamine receptors. Official Gazette of the United States Patent and Trademark Office Patents 1237(3)

Lorenz, K.; Willms, L.; Bauer, K.; Bieringer, H. 2001: Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)

Blurton, P.; Burkamp, F.; Cheng, S.K. Fung; Fletcher, S.R.; Macleod, A.M.; Spinks, D.; Van Niel, M.B. 2003: Phenylsulphonyl derivatives as 5-HT receptor ligands. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)

Kramer, W.; Wachendorff Neumann, U.; Erdelen, C.; Turberg, A.; Mencke, N. 2000: Phenylthio-oxazoline compounds and their use as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1231(4)

Johns, A.; Porter, R.A.an 2002: Phenylurea and phenylthio urea derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Alexieva, V.; Iliev, L.; Karanov, E. 1999: Phenylurea cytokinins-physiological and applied approaches. Biologia Plantarum 42(Suppl ): S81

Jordan, S.L.; Golden, M.D.; Henry, J.; Corbett, T.; West, C.; Hui, R.; Passarelli, J. 2002: Phenytoin ONLINE TDM assay performance on the Roche/Hitachi 917 analyzer. Clinical Chemistry 48(6 Suppl): A48

Bento, A.; Menezes, O.; Vinagre, C. 2001: Phenytoin and valproic acid determinations by two different methods Immulite 2000, DPC LA, and Opus, Dade Behring. Clinical Chemistry 47(S6): A73-A74

Dager, W.E. 2002: Phenytoin assay errors in uremia. Annals of PharmacoTherapy 36(5): 939-940

Liu, H.W.; Payne, H.R.; Brady, S.T. 1999: Phenytoin blocks the action of corticosterone on microtubule and synapse associated proteins. Journal of Neurochemistry 72(Suppl ): S58

Tan, E.K.; Chan, L.L.; Auchus, A.P. 2001: Phenytoin cerebellopathy without epilepsy. Acta Neurologica Scandinavica 104(1): 61-62

Cunningham, M.O.; Wood, S.J.; Jones, R.S.G. 1999: Phenytoin enhances spontaneous GABA-mediated inhibition in the rat entorhinal cortex. British Journal of Pharmacology 127(Proceedings Suppl ): 49P

Quiñones, M.D.; Valero, C.; Salcedo, M.; Sánchez, I.; Jerez, J.; Matorras, P. 1999: Phenytoin hypersensitivity syndrome with fatal evolution. Allergy 54(1): 83-84

Wang, H.; Faucette, S.; Graham, R.; Sueyoshi, T.; Negishi, M.; Lecluyse, E. 2003: Phenytoin induction of CYP3A4 and 2B6 involves a PXR-independent signaling pathway. Drug Metabolism Reviews 35(Suppl 2): 118

Bertholf, R.; Johannsen, L.; Verstraete, A.; De Bel, A.; Jones, J.; Sargent, D.; Luthe, H.; Oellerich, M.; Rhode, K.H.; Roeddiger, R.; Sauter, H.; Coffing, M.J. 2004: Phenytoin measured by kinetic interaction of microparticles in solution homogeneous immunoassay Multisite evaluation of the Roche OnLine TDM method. Clinical Chemistry 50(6, Suppl S, Part 2): A133-A134

Adar, L.; Bialer, M.; Blotnick, S.; Caraco, Y. 2003: Phenytoin metabolic ratio correlates with formation clearance of -7-OH-warfarin. Tulunay, F C, Orme, M European collaboration: Towards drug development and rational drug therapy: 171

Muszkat, M.; Kraselnikov, I.; Elami, A.; Caraco, Y. 2002: Phenytoin metabolic ratio correlates with warfarin dose requirement. Clinical Pharmacology and Therapeutics 71(2): P37

Addicks, W.J.; Duda, J.P.; Snider, D.A.; Benson, K.R. 2001: Phenytoin sodium pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)

Moddel, G.; Cucullo, L.; Marchi, N.; Bingaman, W.; Dombrowski, S.M.; Najm, I.; Janigro, D. 2003: Phenytoin suppresses epileptiform field potentials in human brain slices from patients with pharmacoresistant epilepsy despite increased expression of multidrug resistance 1 gene product P-glycoprotein. Epilepsia 44(Suppl 9): 244

Rosemergy, I.; Findlay, M. 2002: Phenytoin toxicity as a result of 5-fluorouracil administration. New Zealand Medical Journal 115(1159): U124

Gelineau Van Waes, J.; Bennett, G.D.; Finnell, R.H. 1999: Phenytoin-induced alterations in craniofacial development Involvement of the retinoic acid receptors. Teratology 59(6): 381

Sharif, R.N.; Yashpal, K.; Henry, J.L. 1999: Phenytoin-induced anti-hyperalgesia but not antinociception in the rat tail-flick test. Society for Neuroscience Abstracts 25(1-2): 1943

Onodera, K.; Atsushi, T.; Takashi, S.; Hideaki, M.; Hisashi, S. 1999: Phenytoin-induced osteopenia and its prevention with 1alpha D3 or 1alpha,25 2D3 in growing rats. Japanese Journal of Pharmacology 79(Suppl 1): 277P

Mannelli, M. 2003: Pheochromocytoma: a permanent challenge for the clinical endocrinologist. Journal of Endocrinological Investigation 26(5): 387-388

Ross, J.H. 2000: Pheochromocytoma. Special considerations in children. Urologic Clinics of North America 27(3): 393-402

Meraney, A.M.; Gill, I.S.; Bravo, E.L.; Novick, A.C. 1999: Pheochromocytoma co-existing with renal artery lesions Implications for laparoscopic adrenalectomy. Journal of Endourology 13(Suppl 1): A87

Koch, C.A.; Mauro, D.; Walther, M.M.; Linehan, W.M.; Vortmeyer, A.O.; Pacak, K.; Chrousos, G.P.; Zhuang, Z.; Lubensky, I.A. 2001: Pheochromocytoma in VHL disease A distinct histopathological phenotype of hereditary pheochromocytoma. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S25

Diamond, J.A. 2001: Pheochromocytoma in a symptomatic patient with severe hypertension upon anesthesia induction. American Journal of Hypertension 14(7 Part 1): 729-730

Correia, M.J.; Bogalho, M.J.; Lopes, L.O.; Cristina, M.L.; Campo, M.A.; Bordalo, A.D.; Santos, I.; Santos, A.I.; Pinho, B.; Silva, H.; Tuna, J.L.; Diaz, M. 1999: Pheochromocytoma included in multiple endocrine neoplasia type 2A A validation of the genetic screening. Circulation 100(18): 1; 33

Moran, M.E.; Lehr, D.J.; Zornow, D.H.; Kim, D.H.; Abrahams, H.M. 2001: Pheochromocytoma multisystem crisis Probable contraindication for laparoscopic adrenalectomy. Journal of Endourology 15(Suppl 1): A26

Wu, J.S.; Ahya, S.N.; Reploeg, M.D.; Singer, G.G.; Brennan, D.C.; Howard, T.K.; Lowell, J.A. 2000: Pheochromocytoma presenting as a giant cystic tumor of the liver. Surgery 128(3): 482-484

Brown, K.; Stork, C.; Cantor, R. 2001: Pheochromocytoma unmasked by imipramine. Journal of Toxicology. Clinical Toxicology 39(5): 490

Fitzgerald, P.T.; Young, W.F.J.; Ackerman, M.J. 2004: Pheochromocytomas and QT interval prolongation A case series of 50 patients. Journal of the American College of Cardiology 43(5 Suppl A): 141A

Mauro, D.J.; Walther, M.; Yousem, S.; Jaffe, R.; Zhuang, Z.; Klauser, R.D.; Linehan, W.M.; Lubensky, I.A. 1999: Pheochromocytomas in Von Hippel-Lindau disease Comparative histopathologic analysis with MEN2, familial, NOS and sporadic pheochromocytomas. Modern Pathology 12(1): 68A

Gillam, M.P.; Landsberg, L. 2002: Pheocliromocyroma. Molitch, Mark E Contemporary Endocrinology Challenging cases in endocrinology: 155-183

Spratt, T.E.; Larios, E.; Reed, J.; Albino, A.P. 2001: Pheomelanin precursors are more mutagenic than eumelanin precursors in Salmonella mutagenicity tests Implications for melanoma etiology. Proceedings of the American Association for Cancer Research Annual Meeting 42: 807

Siffel, P.; Vacha, F. 2001: Pheophytin reduction and fluorescence quenching in reaction centre of photosystem II. Photosynthesis Research 69(1-3): 185-186

Christensen, T.A.; Hildebrand, J.G. 2002: Pheromonal and host-odor processing in the insect antennal lobe: how different?. Current Opinion in Neurobiology 12(4): 393-399

Seidelmann, K.; Ferenz, H.J. 2002: Pheromonal courtship inhibition in desert locusts, Schistocerca gregaria. Zoology (Jena) 105(Suppl 5): 29

Ichikawa, M. 2003: Pheromonal memory and reproduction. Neuroscience Research Suppl (26): S10

Morgan, C.; Cone, R.D. 2000: Pheromonal regulation of energy homeostasis in Syrian hamsters. FASEB Journal 14(4): A432

Howse, Philip Edwin 2002: Pheromone baits for social insects. Official Gazette of the United States Patent and Trademark Office Patents 1255(1)

Swasdipan, N.; Ebert, P.R. 1999: Pheromone binding protein gene regulation is correlated with behavioural specialisation in the honey bee. Society for Neuroscience Abstracts 25(1-2): 389

Witzgall, P.; Trematerra, P.; Liblikas, I.; Bengtsson, M.; Unelius, C.R. 2010: Pheromone communication channels in tortricid moths: lower specificity of alcohol vs. acetate geometric isomer blends. Bulletin of Entomological Research 100(2): 225-230

Kosted, P.; Sherwood, J. 2001: Pheromone derived peptides from Ustilago hordei competitively inhibit the native activity of the enzyme farnesyltransferase. Phytopathology 91(6 Suppl): S50

Knipple, D.C.; Roelofs, W.L.; Miller, S.J. 1999: Pheromone desaturases. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 488

Nagnan, L.M.illour, P.; Jacquin Joly, E.; Descoins, C. 2002: Pheromone detection and insect pests control. Comptes Rendus de l'Academie d'Agriculture de France 88(4): 33-38

Baum, M.J. 2002: Pheromone detection by the main olfactory system and mammalian gender recognition. Biology of Reproduction 66(Suppl 1): 93

Quong, D. 2003: Pheromone immobilized in stable hydrogel microbeads. Official Gazette of the United States Patent and Trademark Office Patents 1270(2)

Severin, F.F.; Hyman, A.A. 2002: Pheromone induces programmed cell death in S. cerevisiae. Current Biology: Cb 12(7): R233-R235

Mori,K.; Tashiro,T.; ZhaoBoGuang; Suckling,D.M.; El-Sayed,A.M. 2010: Pheromone synthesis Part 243 Synthesis and biological evaluation of -1-Ethyl-2-Methylpropyl 3,13-dimethylpentadecanoate, the major component of the sex pheromone of Paulownia bagworm, Clania variegata, and its stereoisomers. Tetrahedron: 14, 2642-2653

Mabbett, T. 2004: Pheromone trapping indoors - Location and situation. International Pest Control 46(3): 129-132

Carvalho, M.O.; Pereira, A.P.; Mexia, A. 2001: Pheromone traps for monitoring Lasioderma serricorne and Ephestia elutella in stored tobacco in Portugal. Phytoparasitica 29(Suppl): 78S-79S

Babalyan, V.V.; Novikov, S.N. 2001: Pheromone which suppresses spermatogenesis in laboratory mice is associated with urine protein fraction. Doklady Akademii Nauk 378(3): 407-409

Morgan, C.; Novotny, M.V.; Cone, R.D. 2003: Pheromone-induced aggression and preputial gland expression are altered in mice lacking the melanocortin-5 receptor. FASEB Journal 17(4-5): Abstract 793

James, D.G.; Faulder, R.J.; Vogele, B.; Moore, C.J. 2000: Pheromone-trapping of Carpophilus spp Fauna, abundance and seasonality in some Australian horticultural regions. Plant Protection Quarterly 15(2): 57-61

Ando, N.; Shimoyama, I.; Kanzaki, R. 2000: Pheromone-triggered flight motor patterns during free flight were measured by micro-radio transmitter system. Zoological Science 17: 115

Franz, J.T.; Schulz, S.; Fuhlendorff, J.; Masuch, G.; Bergmann, K.C.; Muesken, H. 2001: Pheromones A possible mite avoidance measure?. Allergy 56(Suppl 68): 178

Moynihan, J.A.; Karp, J.D.; Cohena, N.; Ader, R. 1999: Pheromones alter immunity Role of opioids. Neuroimmunomodulation 6(6): 422

Wyatt, T.D. 2003: Pheromones and animal behaviour Communication by smell and taste. Wyatt, Tristram D Author, Reprint Author Pheromones and animal behaviour: Communication by smell and taste i-xv, 1-391

Whittle, C.L.; Bowyer, R.T.; Duffy, L.K.; Drew, K.; Preti, G.; Clausen, T.P. 2002: Pheromones in urine of rutting male moose. Arctic Science Conference Abstracts 53: 240

Shinohara, K.; Morofushi, M.; Kimura, F. 2000: Pheromones that mediate menstrual synchrony in human female. Neuroscience Research Suppl (24): S6

Steinman, R.M.; Pizlo, Z.; Pizlo, F.J. 2000: Phi is not beta. IOVS Investigative Ophthalmology and Visual Science 41(4): S110

Horng, J.-C.; Raleigh, D.P. 2003: Phi-Values beyond the ribosomally encoded amino acids: kinetic and thermodynamic consequences of incorporating trifluoromethyl amino acids in a globular protein. Journal of the American Chemical Society 125(31): 9286-9287

Nobbio, A. 2004: Phial for distributing products, with an improved applicability. Official Gazette of the United States Patent and Trademark Office Patents 1280(5)

Chen, W.; Diers, B.W.; Nelson, R.L. 2001: Phialophora gregata strains pathogenic to resistance allele sources Rbs1 and Rbs3. Phytopathology 91(6 Suppl): S16

Snyder, D.S.; Slovak, M.L.; Bhatia, R.; Arber, D.A. 2002: Philadelphia Chromosome Negative Clones in Philadelphia Chromosome Positive CML Emerging Clinical Implications in Eight Cases. Blood 100(11): Abstract No. 4837

Grudeva, J.; Balatzenko, G.; Krustev, T.; Marichkov, D.; Stefanova, M. 2002: Philadelphia Variant, t , in a Case with Chronic Myeloid Leukemia. Blood 100(11): Abstract No. 4822

Lesesve, J.F.; Troussard, X.; Flandrin, G. 1999: Philadelphia chromosome and p190BCR/ABL rearrangements in myelodysplastic syndromes. Leukemia Research 23(Suppl 1): S45

Nalamolu, Y.; Ballester, O.F.; Hiemenz, J.; Satya Prakash, K.L.; Kulharia, A.S.; Manaloor, E.J.; Mazzella, F.; Kutlar, A. 2003: Philadelphia chromosome positive acute bi-lineage leukemia Originating from a Ph negative clone. Blood 102(11): 241b

Mann, G.; Haas, O.A.; Grumayer Panzer, E.R.; Dworzak, M.N.; Gadner, H. 2001: Philadelphia chromosome positive mature B-cell leukemia. Annals of Hematology 80(Suppl 2): S27

Advani, A.S. 2004: Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia. Leukemia Research 28(6): 545-546

Radich, J.P. 2001: Philadelphia chromosome-positive acute lymphocytic leukemia. Hematology/Oncology Clinics of North America 15(1): 21-36

Scaradavou, A.; Broniscer, A.; Stevens, C.E.; Kurtzberg, J.; Rubinstein, P. 2002: Philadelphia-Chromosome Acute Lymphoblastic Leukemia in Children and Adolescents Outcome with Unrelated Placental Cord Blood Transplantation. Blood 100(11): Abstract No. 3377

Castro Arellano, I.; Zarza, H.; Medellin, R.A. 2000: Philander opossum. Mammalian Species 638: 1-8

Parama, A.; Iglesias, R.; Alvarez, M.F.; Leiro, J.; Aja, C.; Sanmartin, M.L. 2003: Philasterides dicentrarchi Experimental infection and possible routes of entry in farmed turbot. Aquaculture 217(1-4): 73-80, 17 March

Jenkins, A. 1999: Philereme vetulata new to Co Clare. Entomologist's Record and Journal of Variation 111(1): 9

Barcelona, J.F. 2002: Philippine pteridophyte collections as a resource for conservation planning. Fern Gazette 16(6-8): 307-312

Conde, B. 2004: Philippines mental health country profile. International Review of Psychiatry 16(1-2): 159-166

Hartdegen, R.W.; Gamble, K.C. 2002: Phillodryas baroni baroni Endoparasitism. Herpetological Review 33(2): 141

Stiebel, H. 1999: Philloscopus collybita - observation in the lower Eder valley in the mild winter of 1997/98. Vogelkundliche Hefte Edertal 25: 58-60

Argolo, Antonio Jorge Suzart; De Freitas, Marco Antonio 2002: Philodryas aestivus. Herpetological Review 33(3): 229

Moravec,F.; Fajer-Avila,E.J.; Bakenhaster,M. 2010: Philometra floridensis sp n from the ovary of red drum Sciaenops ocellatus off the coast of Florida, USA. Journal Of Helminthology: 1, 49-54

Moravec, F.; Van As, J.G. 2001: Philometroides africanus sp n , a new tissue parasite of the African pike Hepsetus odoe in Botswana. Folia Parasitologica (Ceske Budejovice) 48(2): 127-131

Smetana, A.; Herman, L.H. 1999: Philonthus immundus of Gyllenhal, a misidentification. Coleopterists Bulletin 53(3): 297-298

Kurta, A.; Murray, S.W. 2000: Philopatry and migration of Indiana bats. Bat Research News 41(4): 125-126

Jorgensen, S.J.; Reeb, C.A.; Chapple, T.K.; Anderson, S.; Perle, C.; Van Sommeran, S.R.; Fritz-Cope, C.; Brown, A.C.; Klimley, A.Peter.; Block, B.A. 2010: Philopatry and migration of Pacific white sharks. Proceedings. Biological Sciences 277(1682): 679-688

Coulon, J. 2003: Philorhizus liguricus Sciaky 1990, a new species for the French fauna. Bulletin Mensuel de la Societe Linneenne de Lyon 72(4): 158-160

O'Connor,J.A.; Sulloway,F.J.; Robertson,J.; Kleindorfer,S. 2010: Philornis downsi parasitism is the primary cause of nestling mortality in the critically endangered Darwins medium tree finch. Biodiversity And Conservation: 3, 853-866

Araujo, P.B.; Leistikow, A. 1999: Philosciids with pleopodal lungs from Brazil, with description of a new species. Contributions to Zoology 68(2): 109-141

Flaherty,D. 2010: Philosophical approaches to risk of anaesthetic overdose. Veterinary Times: 7, 28-32

Lugowski, W. 2002: Philosophical foundations of the theories on the origin of life. Origins of Life and Evolution of the Biosphere 32(5-6): 516-517

Robbins,J.E.; Houston,E.; Dummer,G.M. 2010: Philosophies and expectations of wheelchair and stand-up collegiate basketball coaches. Journal Of Sport Behavior: 1, 42-62

Miyawaki, A. 2001: Philosophy and practice of ecology in Japan in special regards to forest restoration. Ecological Society of America Annual Meeting Abstracts 86: 27

Stevens, Michael, C.G. 2003: Philosophy of treatment and the role of chemotherapy in paediatric soft tissue sarcomas. EJC Suppls 1(6): 237-247

Senter, P. 2000: Philothamnus heterodermus Defense. Herpetological Review 31(3): 179

Lilas, L.A.; Mumtaz, F.H.; Madders, D.J.; McNicholas, T.A. 1999: Phimosis after penile Mondor's phlebitis. Bju International 83(4): 520-521

Buyukalpelli, R.; Sarikaya, S.; Asci, R. 1999: Phimosis and circumcision in children. European Urology 35(1)

Ito, K. 2000: Phimosis curing appliance. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)

Valente, M. 2003: Phitoestrogens efficacy on bone loss risk. Calcified Tissue International 72(4): 381-382

Doi, K.; Wanibuchi, H.; Wei, M.; Morimura, K.; Mitsuhashi, M.; Hoshi, M.; Shen, J.; Fukushima, S. 2003: PhlP, a genotoxic carcinogen, has a practical threshold; evidence in AOM-PhlP-induced rat colon carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 44: 286-287

Lundell, T.; Hilden, K.; Hatakka, A.; Martinez, A.T. 2003: Phlebia radiata MnP and LiP enzymes Phylogenetic diversity and a new cluster within the fungal ligninolytic peroxidases. FEMS Congress of European Microbiologists Abstract Book 1: 85

Farias, E.; Gonzalez, E.; Estrada, S. 2001: Phlebitis related to chemotherapy in oncological patients. European Journal of Cancer 37(Suppl 6): S416

Deschamps, J.; Moreno, G. 1999: Phlebopus bruchii An edible fungus from Argentina with possible commercial value. Mycotaxon 72: 205-213

Ibanez Bernal, Sergio 2002: Phlebotominae of Mexico III The species of Lutzomyia Barretto, of the Aragoi group, of L Barretto, of the Dreisbachi group, and of L Barretto. Folia Entomologica Mexicana 41(2): 149-183

Ibanez Bernal, Sergio 2003: Phlebotominae of Mexico IV Species of Lutzomyia Mangabeira, L Barretto, Lutzomyia grupo Oswaldoi, L Barretto and ungrouped species of the genus. Folia Entomologica Mexicana 42(2): 109-152

Marcondes, C.B.; Conceicao, M.B.E.; Portes, M.G.T.; Simao, B.P. 2000: Phlebotomine fauna in a focus of dermal leishmaniasis in the eastern region of Santa Catarina State, southern Brazil Preliminary observations. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 328

Cardenas, R.; Gutierrez, M.; Angulo, V.M.; Munstermann, L.E.; Sandoval, M.; Ferro, C. 2000: Phlebotomine sand flies associated with transmission of urban cutaneous leishmaniasis in northwestern Colombia. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 377-378

Svobodova, M.; Sadlova, J.; Votypka, J.; Volf, P.; Chang, K.P. 2000: Phlebotomine sandflies and rodents in endemic focus of Leishmania tropica in Urfa, Turkey. Journal of Eukaryotic Microbiology 47(2): 8A, March-April

Niang, A.A.; Ba, Y.; Trouillet, J.; Fontenille, D. 2002: Phlebotomine sandflies of Senegal First description of the male of Sergentomyia herollandi Abonnenc, 1960, and redescription of the female. Bulletin de la Societe Entomologique de France 107(4): 429-433

Barral, A. 1999: Phlebotomines and Leishmania Molecular epidemiological, approaches for understanding leishmaniasis transmission. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 19

Svobodova, M.; Votypka, J.; Peckova, J.; Jacobson, R.L.; Warburg, A. 2004: Phlebotomus arabicus - a new vector of Leishmania tropica. Journal of Eukaryotic Microbiology 51(2): 20A

Picado,A.; Das,M.L.; VijayKumar; Dinesh,D.S.; SumanRijal; Singh,S.P.; PredeepDas; Coosemans,M.; Boelaert,M.; Davies,C. 2010: Phlebotomus argentipes seasonal patterns in India and Nepal. Journal Of Medical Entomology: 2, 283-286

Casinelli, K.; Nobili, C.; Limodio, M.; Anzalone, E.; Fabrizi, P.; Falco, M.C.; Petrucci, A.; Sarracino, L.; Savo, M.; Gallo, A.; Ceccarelli, A. 1999: Phlebotomy efficacy before interferon therapy in a case of chronic C hepatitis and hemocromatosis. Journal of Hepatology 30(Suppl 1): 266

Fernandez Real, J.M.; Penarroja, G.; Castro, A.; Lainez, B.; Viejo, A.L.; Garcia Bragado, F.; Ricart, W. 2000: Phlebotomy improves vascular dysfunction in type 2 diabetes mellitus. Diabetologia 43(Suppl 1): A54

Desai, T.K. 2000: Phlebotomy reduces transaminase levels in patients with non-alcoholic steatohepatitis. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A975

Conry-Cantilena, C. 2001: Phlebotomy, blood donation, and hereditary hemochromatosis. Transfusion Medicine Reviews 15(2): 136-143

Gaulke, R. 2003: Phlegmon of the forearm due to therapy with Anakinra. Zeitschrift fuer Rheumatologie 62(6): 566-569

Bobrov, V.M.; Lysenko, V.A. 2003: Phlegmon of the neck. Vestnik Otorinolaringologii 5: 61-62

Dorosh, A.; Hasek, J.; Janatova, I. 2003: Phleomycin and zeocin as selective agents in transformation of Schwanniomyces occidentalis. FEMS Congress of European Microbiologists Abstract Book 1: 466

Durand, M.F.; Connellan, S.J.; Nagendran, V.; Nelson, P.N.; Perera, S. 1999: Phleum pratense pollen specific immunoglobulin A detection in the saliva of 35 adults by a novel indirect ELISA. Immunology 98(Suppl 1): 140

Van Neerven, R.J.J.; Wissenbach, M.; Arnved, J.; Ipsen, H. 1999: Phleum pratense-specific T-cells of allergic rhinitis patients display a broader recognition pattern than Phleum pratense-specific serum IgE. Journal of Allergy and Clinical Immunology 103(1 Part 2): S108

Botha, C.E.J. 2003: Phloem loading in grasses An apoplasmic main event with a slow symplasmic sideshow. South African Journal of Botany 69(2): 226

Lemoine, R. 2002: Phloem structure and functions in higher plants. Comptes Rendus de l'Academie d'Agriculture de France 88(8): 57-62

Klingler, J.; Thompson, G.A.; Perl Treves, R. 1999: Phloem-specific aphid resistance in melon. Plant Biology (Rockville) : 17

Liu, Q.; Zhao, Y.; Davis, R.E. 2003: Phloem-specific expression of the beta-glucuronidase reporter gene in transgenic strawberry. In Vitro Cellular and Developmental Biology. Plant 39: 43A

Uchiyama, M.; Kim, S.H.; Akaike, T. 2001: Phloretin induced apoptosis in primary cultured hepatocetes. Cell Structure and Function 26(5): 459

Miller, J.S.; Manalis, R.S. 2003: Phloretin inhibits membrane water transport in avian erythrocytes. FASEB Journal 17(4-5): Abstract 591

Stewart, G.S.; Fenton, R.A.; Thevenod, F.; Smith, C.P. 2002: Phloretin-inhibitable urea transport in the mouse colon. Journal of Physiology (Cambridge) 544P: 94P

Bush, Eugene N.; Shapiro, D. Robin; Adler, Andrew L.; Kramer, Deborah L.; Wu Wong, Jinshyun R.; Jacobson, Peer; Opgenorth, Terry J. 1999: Phlorizin treatment of Zucker Diabetic Fatty rats for one week decreased blood glucose and triglycerides without significant alterations of urine volume, glucosuria, renal function, or insulin resistance. Diabetes 48(Suppl 1): A281

Hwu, J.R.; Tsay, S.C.; Hakimelahi, G.H.; Lin, C.C.; Tseng, W.N.; Moshfegh, A.A.; Azaripour, A.; Mottaghian, H. 2000: Phloroglucide derivatives and their pharmceutical use. Official Gazette of the United States Patent and Trademark Office Patents 1238(3)

Hwu, J.R.; Tsay, S.C.; Hakimelahi, G.H.; Lin, C.C.; Tseng, W.N.; Moshfegh, A.A.; Azaripour, A.; Mottaghian, H. 2001: Phloroglucidic acid and derivatives as antibacterial agents. Official Gazette of the United States Patent and Trademark Office Patents 1250(2)

Brock, E.; Aberg, P.; Pavia, H. 2001: Phlorotannins as chemical defense against macroalgal epiphytes on Ascophyllum nodosum. Journal of Phycology 37(3 Suppl): 8

Nishizawa, M.; Toh, E.; Akio 2003: Pho85 kinase is involved in the diauxic shift of the yeast Saccharomyces cerevisiae. Yeast 20(Suppl 1): S266

Black, M.T.; Hodgson, J.E.; Knowles, D.J. Charles; Reichard, R.W.; Nicholas, R.O.; Burnham, M.K. Russel; Pratt, J.M.; Rosenberg, M.; Ward, J.M.; Lonetto, M.A.; Warren, P.V. 2001: PhoH homolog. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)

Villa Ramirez, Bernardo 2002: Phocoena sinus Norris and McFarland, 1958. TIP Revista Especializada en Ciencias Quimico-Biologicas 5(1): 20-28

Foster, G.; Ross, H.M.; Malnick, H.; Willems, A.; Hutson, R.A.; Reid, R.J.; Collins, M.D. 2000: Phocoenobacter uteri gen nov, sp nov, a new member of the family Pasteurellaceae Pohl 1981 isolated from a harbour porpoise. International Journal of Systematic and Evolutionary Microbiology 50(6 part 1): 135-139

Yildirim, E. 2002: Phoenicocoris obscurellus a new record and a new scotch pine pest for Turkey from Erzurum. Turkiye Entomoloji Dergisi 26(1): 45-49

Masuoka, Y.; Shin-Ya, K.; Furihata, K.; Nagai, K.; Suzuki, K.; Hayakawa, Y.; Seto, H. 2001: Phoenistatin, a new gene expression-enhancing substance produced by Acremonium fusigerum. Journal of Antibiotics 54(2): 187-190

Riegl, B. 2002: Phoenix from the ashes? Repetitive mass mortality and the biogeology of southern Arabian Gulf coral systems. Bright, Monika , Reprint Author, Dworschak, Peter C, Stachowitsch, Michael , Reprint Author The Vienna School of Marine Biology: A tribute to Joerg Ott: 137-159

Shochat, E.; Katti, M. 2001: Phoenix or Tucson Does landscape structure influence where Aberts Towhees choose to live?. Ecological Society of America Annual Meeting Abstracts 86: 343

Hutton, J.C.; Wasmeier, C.; Bright, N.; Kelemen, K.; Zahn, T.; Bergman, B. 2001: Phogrin A dense core granule membrane protein of neuroendocrine tissues. Regulatory Peptides 97(1): 25, 2 February

Wasmeier, C.; Hutton, J.C. 1999: Phogrin, an insulin granule membrane PTP homologue, is phosphorylated during stimulated insulin release. Diabetologia 42(Suppl 1): A135

Zalacain, M.; Brown, J.R. 1999: Phoh. Official Gazette of the United States Patent and Trademark Office Patents 1220(4): 3509

Reichl, S.; Arnhold, J.; Benard, S.; Arnold, K. 1999: Pholasin chemiluminescence as a tool for detecting reactive oxygen species and myeloperoxidase in neutrophils. European Journal of Clinical Investigation 29(Suppl 1): 52

Hastings, P.A.; Springer, V.G. 2002: Pholidichthys anguilliformis Lockington, 1881 , a junior synonym of Pholis ornata. Proceedings of the Biological Society of Washington 115(3): 543-545

Cortez, V.G.; Coelho, G. 2003: Pholiota spumosa singer First record from Rio Grande do Sul, Brazil. Biociencias (Porto Alegre) 11(2): 133-136

Koike, S.T.; Subbarao, K.V.; Verkley, G.J.M.; O'neill, T.; Fogle, D. 2003: Phoma basal rot of lettuce caused by P exigua in California. Phytopathology 93(6 Suppl): S47

White, James, F.Jr 2003: Phoma glomerata ATCC MYA-2373 for biocontrol of fungal diseases in plants. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)

Padgett, G.B. 2000: Phomopsis boll dangle epidemics in two cotton cultivars. Phytopathology 90(6 Suppl): S58

Catlin, N.J.; Caruso, F.L. 2002: Phomopsis vaccinii as a probable causal agent of upright dieback of cranberry. Phytopathology 92(6 Suppl): S12

Zowtiak, J.; Young, T.; Wondka, T. 2002: Phonation valve for breathing tube. Official Gazette of the United States Patent and Trademark Office Patents 1254(1)

Deforche, B.; De Bourdeaudhuij, I.; Tanghe, A.; Hills, A.P.; Bouckaert, J. 2002: Phone contact as a follow-up strategy in the treatment of obese children. International Journal of Obesity 26(Suppl 1): S11

Elasy, T.A.; Spickard, A.; Pichert, J.; Swiggart, W.; Dixon, G. 1999: Phone requests for medication refill in a teaching practice. JGIM 14(Suppl 2): 95

Lipton, R.B.; Katz, M.; Kuslansky, G.; Buschke, H.; Verghese, J. 2002: Phone-based screening for dementia in the general population Results from the Einstein Aging Study. Neurology 58(7 Suppl 3): A100

Costa, S.K.P.; Antunes, E.; De Nucci, G.; Brain, S.D.; Docherty, R.J. 2001: Phoneutria nigriventer spider venom activates Na+ channels in the rat vagus nerve in vitro. Journal of Physiology (Cambridge) 531P: 221P-222P

Chanques, G.; Jaber, S.; Delay, J.M.; Perrigault, P.F.; Lefrant, J.Y.; Eledjam, J.J. 2003: Phoning study about postoperative practice and application of non-invasive ventilation. Annales Francaises D'anesthesie et de Reanimation 22(10): 879-885

Martin, R.; Preiksaitis, H.; Lloyd, D.A. 2000: Phonoenterography for evaluation of small bowel motor motility. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1188

Vliet, E.Caccappolo-van.; Miozzo, M.; Stern, Y. 2004: Phonological dyslexia without phonological impairment?. Cognitive Neuropsychology 21(8): 820-839

Hughes, J.D.; Heilman, K.M. 1999: Phonological interference in conduction aphasia. Neurology 52(6 Suppl 2): A489

Hemmerling, T.M.; Donati, F.; Beaulieu, P.; Babin, D. 2002: Phonomyography Is the duration of control stimulation important?. Anesthesia and Analgesia 94(2S Suppl): S 139

Gavriely, N. 2001: Phonopneumograph system. Official Gazette of the United States Patent and Trademark Office Patents 1248(3)

Macklem, P.T.; Que, C.L.; Kelly, S.M.; Kolmaga, K.; Durand, L.G.lles 2001: Phonospirometry for non-invasive monitoring of respiration. Official Gazette of the United States Patent and Trademark Office Patents 1247(1)

Lakes Harlan, R.; Stoelting, H.; Moore, T.E. 2000: Phonotactic behaviour of a parasitoid fly in response to the calling song of its host Cicada. Zoology (Jena) 103(1-2): 31-39

Mason, A.C.; Hoy, R.R. 2001: Phonotaxis in the acoustic parasitoid fly Ormia ochracea. Advances in Ethology 36: 213

Hebert, I.; Khaimskiy, Y.; Athar, M.; Kopelovich, L.; Bickers, D.; Epstein, E. 2004: Phorbol 12-myristate 13-acetate inhibits the induction of basal cell carcinomasin Ptch1+/- mice. Journal of Investigative Dermatology 122(3): A28

Rahmani, M.; Grant, S. 2002: Phorbol 12-myristate 13-acetate interacts synergistically with the checkpoint abrogator 7-hydroxystaurosporine to induce mitochondrial damage and apoptosis in U937 human myeloid leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 66

Wang, X.F.; Wang, Q.D.; Hu, W.Q.; Thomas, R.P.; Evers, B.M. 2002: Phorbol 12-myristate 13-acetate upregulates expression of proapoptotic genes and increases the sensitivity of Panc-1 cells to TRAIL. Gastroenterology 122(4 Suppl 1): A-242

Uno, T.; Kawahara, J.; Tanako, A.; Iwata, M.; Haruta, T. 2001: Phorbol 12-myristate 13-acetate-induced insulin resistance is mediated by a mammalian target of rapamycin pathway. Diabetes 50(Suppl 2): A288

Hussaini, I.M.; Karns, L.R.; Vinton, G.; Carpenter, J.; Redpath, G.T.; Sando, J.J.; Vandenberg, S.R. 1999: Phorbol 12-myristate-13-acetate induces protein kinase C-eta-specific cell proliferative response in astrocytic tumor cells. Society for Neuroscience Abstracts 25(1-2): 1798

Hattori, M. 2001: Phorbol derivatives having antivirus activity. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)

Mazer, B.; Zhuang, Q.L.; Bastein, Y.; Zhang, J.H. 1999: Phorbol ester and calcium ionophore downregulates platelet-activating factor receptor expression in a B lymphoid cell line. Journal of Allergy and Clinical Immunology 103(1 Part 2): S241

Chen, C.S.; Chen, W.N. U. 2000: Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. Molecular Biology of the Cell 11(Suppl): 524a

Yuziuk, J.A.; Daniel, L.W. 2000: Phorbol ester induces prostaglandin endoperoxide H synthase-2 expression via A p38 map kinase-dependent pathway in a human colorectal adenocarcinoma cell line. Proceedings of the American Association for Cancer Research Annual Meeting 41: 63

Biro, T.; Boczan, J.; Papp, H.; Kovacs, L. 2000: Phorbol ester treatment inhibits proliferation and differentiation of cultured human skeletal muscle cells by differentially acting on protein kinase C isoforms. Journal of Physiology (Cambridge) 526P: 32P-33P

Hamamoto, Y.; Nagai, K.; Ogasawara, Y.; Inoue, K.; Ichimiya, M.; Muto, M. 2001: Phorbol ester-induced apoptosis associated with syncytia formation in human monocytic cell lines established from peripheral blood of patients with atopic dermatitis and psoriasis. Journal of Investigative Dermatology 117(2): 463

Powell, C.Thomas 1999: Phorbol ester-induced apoptosis of human prostate cancer cells involves prolonged activation of the MAP kinase pathway and correlates with expression of RasGRP mRNA. Proceedings of the American Association for Cancer Research Annual Meeting 40: 580

Wang, Q.; Wang, X.; Thomas, R.P.; Walker, S.L.; Hellmich, M.R.; Evers, B.M.rk 2002: Phorbol ester-induced cIAP2 expression in human colon cancer cells is dependent on the novel protein kinase C-delta. Proceedings of the American Association for Cancer Research Annual Meeting 43: 530

Heldt, C.; Hass, R. 1999: Phorbol ester-induced differentiation of human myeloid leukemia cells is inhibited by antisense CD11b integrin expression. European Journal of Cell Biology 78(Suppl 49): 38

Schwager, S.L.U.; Chubb, A.J.; Scholle, R.R.; Naidoo, K.; Brandt, W.F.; Eckerskorn, C.; Sturrock, E.D.; Ehlers, M.R.W. 1999: Phorbol ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is not inhibited by a disulfide-bridged stalk. Biochemical Society Transactions 27(1): A56

Loos, J.C.; Garzotto, M. 2003: Phorbol ester-mediated apoptosis in LNCaP cells is P53-independent. Journal of Urology 169(4 Suppl): 219

Wang, X.; Wang, Q.; Evers, B.M.rk 2001: Phorbol ester-mediated neurotensin gene induction is regulated by a Ras/PKC/ATF-2 dependent pathway. Gastroenterology 120(5 Suppl 1): A 309

Bobrovskaya, L.; Cheah, T.B.; Dunkley, P.R. 1999: Phorbol ester-mediated phosphorylation of tyrosine hydroxylase in bovine adrenal chromaffin cells. Journal of Neurochemistry 72(Suppl ): S25

Chang, P.L.; Chambers, A.F.; Prince, C.W. 1999: Phorbol ester-treated mouse epidermal cells bind to osteopontin through alphav-containing integrin. Proceedings of the American Association for Cancer Research Annual Meeting 40: 462

Chang, R.L.; Han, Z.T.o 2000: Phorbol esters as anti-neoplastic and white blood cell elevating agents. Official Gazette of the United States Patent and Trademark Office Patents 1234(3)

Jones, K.S.; Ruscetti, F.W.; Sadowski, C.; Nath, M. 2001: Phorbol esters down modulate expression of cell surface protein critical for direct binding of an HTLV-1 SU fusion protein. AIDS Research and Human Retroviruses 17(Suppl 1): S 22

Nie, Z.; Mei, Y.; Ramkumar, V. 1999: Phorbol esters increase A1 adenosine receptor expression by activation of AP-1 and NFkappaB transcription factors. FASEB Journal 13(4 Part 1): A462

Jin, S.; Schatter, B.; Koetter, K.; Weichel, O.; Park, J.B.; Ryu, S.H.; Klein, J. 2000: Phorbol esters increase activity and gene expression of phospholipase D in astrocytes. Chemistry and Physics of Lipids 107(1): 38

Fultz, M.E.; Li, C.; Wright, G.L. 2001: Phorbol induced remodeling of the actin cytoskeleton in the contracting A7R5 smooth muscle cell. FASEB Journal 15(5): A1126

Kikuchi, M.; Tachimoto, H.; Hudson, S.A.; Bochner, B.S. 2000: Phorbol myristate acetate alters human eosinophil expression of alpha4beta1 and alphadbeta2 integrins and adhesion to VCAM-1 under static and flow. Journal of Allergy and Clinical Immunology 105(1 part 2): S258

Pedron, T.; Girard, R.; Chaby, R. 2000: Phorbol myristate acetate blocks LPS-induced expression of membrane CD14 in mouse bone marrow granulocytes Involvement of PKC-alpha. Journal of Endotoxin Research 6(2): 133

Kharazi, A.I.; Kudinov, Y.G.; Escobar, A.I.; Wiseman, C.L. 2000: Phorbol myristate acetate can potentiate gamma-interferon-induced up-regulation of MHC Class II antigens in tumor cell lines. Journal of Immunotherapy 23(5): 589

Kiningham, Kelley; Xu, Yong; Daosukho, Chotiros; Popova, Bilyana; St Clair, Daret K. 1999: Phorbol-12-myristate 13-acetate enhances cytokine inducibility of the SOD2 gene. Free Radical Biology and Medicine 27(Suppl 1): S62

Lahad, I.; Katz, R.; Pollack, S. 2000: Phorbol-ester stimulated MAPK activity in human monocytic cell lines is partially PKC-dependent and is related to the monocytic maturation state. FASEB Journal 14(6): A1063

Li, C.; Fultz, M.E.; Geng, W.; Wright, G.L. 2000: Phorbol-induced PKCalpha translocation to different subcellular sites is concentration-dependent and requires an intact cytoskeleton in A7r5 cells. FASEB Journal 14(4): A417

Kato, A.; Fukazawa, Y.; Fujitani, K.; Inokuchi, K.; Sugiyama, H. 1999: Phorbolester promotes synaptic distribution of Vesl-1S/Homer-1a protein which is upregulated during long-term potentiation. Society for Neuroscience Abstracts 25(1-2): 466